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ABSTRACT
Late in Drosophila embryogenesis the cells giving rise to most of the larval tissues
switch from a mitotic cycle to the endo cycle. The endo cycle consists of only S phase
and a gap phase, leading to polyteny. It is preceded by the first detectable G1 period
in Drosophila embryogenesis and developmentally regulated induction of S phase
genes in the pattern of DNA synthesis. My analysis of the regulation of G1-S
progression began with a genetic screen for mutations that disrupt the transcription
pattern of S phase genes in mitotic and polytene cells of the embryo. A number of
mutations in known and novel genes were isolated. Further analysis and phenotypic
characterization has focused on the mutations that nearly eliminate the
transcription of S phase genes in mitotic and polytene cells. These mutations are in
the Drosophila homologs to the mammalian E2F and DP genes. The E2F
transcription factor, a heterodimer of E2F and DP subunits, is linked to the G1-S
transition in mammalian cells. Five mutations in the Drosophila DP gene (dDP) were
isolated and provide the first opportunity to examine the in vivo role of this gene.
Despite a pronounced effect on the G1-S transcription of S phase genes in dDP and
dE2F mutant embryos, a block to replication was not observed. Null mutations in
dDP and dE2F cause lethality late in development with some mitotic and polytene
tissues being underdeveloped or absent. The mutant phenotypes reveal a positive
role for E2F/DP in cell cycle progression in mitotic and endo cycle cells. Weak alleles
of dE2F and dDP develop to adulthood and exhibit defects in oogenesis. Analyses of
these mutants showed that E2F/DP controls differential regulation of replication
origins within polyploid S phase. In ovarian nurse cells, E2F/DP limits replication of
heterochromatic sequences. In follicle cells, E2F/DP is required to shut off genomic
replication and activate the amplification of chorion loci. In addition to the positive
and negative effects on the activity of replication origins, E2F/DP is necessary for
nuclear lamin breakdown in nurse cells and subsequent nurse cell apoptosis.
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Chapter One
Introduction
The cell cycle, the ordered sequence of events by which cells grow and divide,
has been studied in diverse organisms including yeasts, frogs, flies, and mammals. A
typical cell cycle consists of a round of DNA replication (S phase) and subsequent
chromosome segregation and cell division (M phase); a G1 gap phase separates the
end of M phase and the beginning of S phase, and a G2 gap phase defines the period
from the end of DNA synthesis to the beginning of the next M phase. S phase and
mitosis alternate with each other to ensure the proper genome ploidy and viability of
daughter cells.
The ability to deviate from the typical cell cycle order, however, is key for a
number of developmental processes. The cell cycle resulting in the production of
haploid gametes, meiosis, requires two rounds of M phase without an intervening S
phase. Many cells become polyploid or polytene. These cells tend to be highly
metabolically active and synthesize large amounts of particular products in a short
period of time. The trophoblast cells that give rise to the mammalian placenta, and
ovarian nurse and follicle cells critical for Drosophila oocyte development are
examples. In fact, 300 examples of polyploidy or polyteny have been observed in
animals, plants, and protozoans (Brodsky and Uryvaeva 1984; Nagl 1978). It has
been demonstrated in Drosophila that polyploid and polytene cells result from an
altered cell cycle in which S phase alternates with gap phase (Hammond and Laird
1985a; Hammond and Laird 1985b; Mahowald, et al. 1979; Pearson 1974; Rudkin
1973; Smith and Orr-Weaver 1991). This modified cell cycle, termed the endo cycle,
excludes cell division. Thus, growth results from an increase in cell size rather than
cell number, and increasing polytenization is the primary mechanism of larval growth
in Drosophila. In addition, 20-30% of the DNA is under-represented in polytene and
polyploid cells due to incomplete replication of late-replicating regions of the genome
(Hammond and Laird 1985a; Lilly and Spradling 1996; Rudkin 1969). This change in
the parameters of S phase begins with the first endo cycle of Drosophila
embryogenesis (Smith and Orr-Weaver 1991).
To isolate S phase controls that either link or distinguish mitotic and polytene
cells, I screened for mutations that disrupt G1-S transcription late in Drosophila
embryogenesis. The mutations that were recovered from this screen are discussed in
Chapter 2. This thesis focuses on the shared regulators of the mitotic and endo cell
cycles, the Drosophila dDP and dE2F genes. The E2F transcription factor, a
heterodimer of E2F and DP subunits, is linked to the G1-S transition in mammalian
cells. In Chapter 3, the effects of null mutations in dDP and dE2F on G1-S
progression in mitotic and polytene tissues are examined. The analysis of weak,
female-sterile dDP and dE2F mutations is presented in Chapter 4; this study links
E2F to the differential use of replication origins within polyploid S phase and to
developmentally-induced apoptosis.
This introductory chapter is divided into three parts. The first part examines
the relationship between the mitotic and endo cell cycle. I discuss the various
mutants and treatments that have provided insights into the molecular mechanism
responsible for the bypass of mitosis in polytene and polyploid cells. Next, I provide
an overview of the G1/S transition in budding yeast, mammalian cells and flies.
Finally, Drosophila oogenesis is presented as a model system for the study of
differential replication.
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Breaking the order of S and M phase
In a typical cell cycle, the onset of S phase depends on the completion of
mitosis. This dependence was illustrated in a series of elegant mammalian cell fusion
experiments. These studies showed that when an M phase cell is fused with a cell in
any other part of the cell cycle, hybrid cells are produced in which all the nuclei enter
mitosis (Johnson and Rao 1970). Fusing an S-phase cell with a G1 cell, induces the
G1 nucleus to replicate its DNA prematurely. Despite the presence of a dominant
inducer of DNA replication in S phase cytoplasm, the fusion of a G2 cell with an S
phase cell does not permit the G2 nucleus to replicate its DNA (Rao and Johnson
1970). Thus, entry into S phase requires the absence of a dominant inducer of
mitosis, removal of the block to replication, and an S phase activator.
The dominant inducer of mitosis is MPF, a complex of protein kinase p34cdc2 and
mitotic cyclin B. MPF has been highly conserved during evolution, and its universal
importance to the regulation of M-phase in eukaryotic cells is established (Nurse
1990). Mitosis is induced due to accumulation of cyclin B during interphase, and the
subsequent degradation of cyclin B inactivates MPF and resets the cell cycle
(Minshull, et al. 1989; Murray and Kirschner 1989; Murray, et al. 1989). In addition,
it has been suggested that mitosis allows an activator of S phase to gain access to
DNA upon nuclear envelope breakdown. A G2 nucleus made permeable with a
membrane disrupting agent and then repaired can undergo rereplication of the DNA
replication in Xenopus egg extracts (Blow and Laskey 1988).
Mutants in fission yeast suggest that p34cdc2-mitotic cyclin B complex
determines the order of S and M phase in the eukaryotic cell cycle (Nurse 1994). The
cdc2 gene (encoding p34cdc2 ) is required in G1 at START when the cell becomes
committed to the cell cycle as well as at M phase (Nurse and Bissett 1981). Heat
treatment of specific temperature-sensitive cdc2 mutations result in DNA replication
without an intervening mitosis: destruction of p3 4cdc2 before the onset of M phase
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resets the cell cycle, and on restoration of p34" 2 function at the permissive
temperature the mutants initiate a second round of S phase instead of undergoing
mitosis (Broek, et al. 1991). Also, cells deleted for cdcl3 (encoding mitotic cyclin B)
undergo repeated rounds of S phase in the absence of mitosis, and overexpression of
cdc2 and cdcl3 in G1 induces premature entry into M phase (Hayles 1994). These
results suggest that the p34cdc2-mitotic cyclin B complex identifies a cell as being in
G2/M, and prevents DNA replication; the absence of this complex in G2 cells after
heat treatment of cdc2t" or elimination of cyclin B is sufficient to overcome the block
to replication. Normally, mitotic cyclin B is degraded at the end of mitosis, and the
cell cycle is reset to G1. Thus, there is a remarkable convergence between the
phenomena revealed by the cell fusion experiments, frog biochemistry and yeast
genetics.
A number of other mutants and treatments also suggest that the mitotic
program inhibits S phase. The fission yeast rum1 gene (encoding an inhibitor of
p34 cdc2) when overexpressed blocks M phase and allows repeated S phases (Moreno
and Nurse 1994). It is known that protein kinase inhibitors can induce S phase
without mitosis in mammalian cells (Usui, et al. 1991). Loss of ts41 function in
Chinese hamster cell lines (at the nonpermissive temperature) also blocks M phase
and results in polyploid cells. The wild-type ts41 gene product is proposed to be
essential for mitosis, and its activity may repress S phase (Handeli and Weintraub
1992).
It seems likely that meiotic cells use cdc2/cyclin B activity to prevent DNA
replication from intervening between the two meiotic divisions. In Xenopus oocytes,
cyclin B persists between the meiotic divisions (Kobayashi, et al. 1991), and the
levels of MPF remain high (Furuno, et al. 1994; Ohsumi, et al. 1994). The high level of
MPF may suppress S Phase. This is consistent with the observation in Xenopus
embryo extracts that the assembly of replication proteins on DNA is inhibited by the
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p34Cdc2-mitotic cyclin B complex (Adachi and Laemmli 1994). Furthermore,
expression of a dominant negative cdc2 or inhibition of Mos in oocytes causes
replication between the meiotic divisions (Furuno, et al. 1994). Mos is needed to
maintain cdc2/cyclin B active. Thus, in both situations the inappropriate round of S
phase may result from a failed cdc2/cyclin B activity.
In contrast to meiotic cells, cells that become polytene or polyploid during the
normal course of development shut off mitotic functions. Indeed, Drosophila endo
cycles do not require cdc2 (Reed and Orr-Weaver 1997; Stern, et al. 1993), and mitotic
functions appear to be shut off in polytene and polyploid cells. Mitotic cyclin B has
not been detected in endo cycle tissues (Lehner and O'Farrell 1990; Lilly and
Spradling 1996). Moreover, mutations in cdc2 cause normally diploid tissues to
become polytene, suggesting that the downregulation of cdc2/cyclin B may be
sufficient to drive repeated rounds of S phase (Hayashi 1996).
It is possible that the mechanism responsible for repressing mitosis in
polytene and polyploid cells involves novel, endo cycle specific regulators. However,
endo cycle cells may utilize the same cell cycle controls that permit mitotic cells to
end mitosis and reset the cell cycle. The effects resulting from mutations in the
Drosophila gene morula support the latter mechanism (Reed and Orr-Weaver 1997).
Nurse cells of the adult ovary become polyploid; mitotic spindles, condensed
chromosomes, and mitotic cyclin B are never observed. In female-sterile morula
mutants nurse cells initiate endo cycles, but then revert to mitosis; the nuclei contain
large mitotic spindles, metaphase-like chromosomes, and cyclin B. The inappropriate
presence of cyclin B in mutant nurse cells suggests that the activity of the
cdc2/cyclin B kinase may be high. Mitotic cells require degradation of the cyclin
subunit of the cdc2/cyclin B kinase for passage though the metaphase/anaphase
transition (for review see King, et al. 1996). In the lethal morula alleles mitotic cells
are blocked at metaphase, suggesting that the cdc2/cyclin B kinase remains active
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(Reed and Orr-Weaver 1997). Thus, morula serves a dual function: it promotes exit
from mitosis in diploid cells and maintains the shut off of mitotic activities in polyploid
cells.
A recent study suggests that the anaphase-promoting complex (APC) is up-
regulated in polyploidizing megakaryocytic cell lines (Zhang, et al. 1998). The levels of
cyclin B1 protein are reduced in these cells and the activity of the ubiquitin pathway
that degrades cyclin B is increased. This is consistent with an observation in
Aspergillus that one of the APC subunits, bimE, inhibits the onset of mitosis (James,
et al. 1995; Osmani, et al. 1991; Osmani, et al. 1988; Peters, et al. 1996). It will be
interesting to determine whether morula encodes a component of the APC in
Drosophila or a regulator that promotes APC activation in polyploid and polytene
cells and in diploid cells at the metaphase/anaphase transition.
The transition from G1 to S phase
The transition between G1 phase and S phase in diploid and polyploid cells is
especially relevant to my thesis because at this point cell cycle progress is
coordinated with developmental events and signals from other cells. The
identification of the molecules that induce S phase in budding yeast and multicellular
eukaryotes suggests that both transcriptional and post-transcriptional regulatory
mechanisms are needed for G1-S progression. Both types of regulation are discussed
in budding yeast, mammalian cells, and Drosophila.
Budding yeast and common themes
In the yeast Saccharomyces cerevisiae a single cyclin dependent protein kinase
Cdc28 (a homologue of fission yeast cdc2) promotes both S and M phase of the cell
cycle. To direct passage through distinct transitions of the cell cycle, Cdc28
associates sequentially with cyclins that allow G1/S progression (Clnl through 3),
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cyclins that are needed during S phase (Clb5 and 6), and those that advance mitosis
(Clbl though 4) (for review see Nasmyth 1996). In the presence of nutrients and
having reached a critical size, G1 cells initiate DNA replication, form buds, and
duplicate their spindle pole body in preparation for subsequent chromosome
segregation and cell division. Also, at this point in late G1 (also known as Start)
mating factors can no longer induce a haploid cell to exit from the cell cycle and mate.
Progression though Start requires the Cdc28 kinase and at least one of the
three Cln cyclins. The inactivation of Cdc28 in G1 cells or mutants lacking all three
Cln cyclins arrest in G1, before Start, as large unbudded cells (Richardson, et al.
1989). All three G1 cyclins are very unstable proteins (Cross 1990; Richardson, et al.
1989; Wittenberg, et al. 1990). Mutations resulting in the increased stability of Cln
proteins or ectopic expression of the Clns cause G1 budding yeast cells to initiate
Start prematurely and at a smaller size than normal, suggesting that the
accumulation of Clns may be rate-limiting for Start (Cross 1988; Hadwiger, et al.
1989; Nash, et al. 1988; Sudbery, et al. 1980). Budding yeast cells deleted for any of
the CLN genes delay in G1 and go through Start at a larger size than their wild-type
counterparts (Cross 1988; Hadwiger, et al. 1989; Nash, et al. 1988).
The CLN1 and CLN2 genes require an active Cln-Cdc28 kinase for their
expression. The CLN1 and CLN2 genes are transcribed during late G1, reaching
maximum levels just prior to Start, and then decline rapidly (Tyers, et al. 1993;
Wittenberg, et al. 1990). CLN1 and CLN2 are part of a larger G1-S transcriptional
program controlled by two related heterodimeric transcription factors, Swi4/Swi6 and
Mbpl/Swi6 (Koch and Nasmyth 1994). Both transcription factors consist of a
common regulatory subunit, Swi6, complexed with a DNA binding subunit (Swi4 or
Mbpl). Swi4/Swi6 target genes include CLN1 and CLN2. Mbpl/Swi6 is needed for
the expression of CLB5 and CLB6 (unstable S phase cyclins) as well as numerous
other S phase genes (Koch and Nasmyth 1994). Mutants lacking both transcription
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factors arrest in the cell cycle in late G1, indicating that passage the G1-S
transcriptional program is essential for Start (Koch, et al. 1993). Cln3 (already
present in early Gl) and Cdc28 jointly trigger the expression of Swi4/Swi6 and
Mbpl/Swi6 dependent genes including CLN1 and CLN2 (Tyers, et al. 1993). This
leads to the synthesis of Clnl and Cln2 proteins and suggests the possibility of a
positive feedback loop for Clnl and Cln2 production; ectopic expression of any one of
the three Clns in a triple clnlcln2cln3 mutant triggers both Start and the
accumulation of CLN1 and CLN2 transcripts (Cross and Tinkelenberg 1991; Dirick
and Nasmyth 1991). The abrupt rise in Cln-Cdc28 kinase activity in late G1 (due to
positive feedback) is thought to result in an irreversible commitment to enter the cell
cycle.
Recent experiments indicate that the role of Cln3 in the regulation of Start
differs from that of Clnl and Cln2. In a cln3 mutant, G1 cells are unable to activate
Swi4/Swi6 and Mbpl/Swi6 target genes until they reach a very large size (Dirick, et
al. 1995). In contrast, in a clnlcln2 double mutant the late G1 transcriptional
program occurs in a timely fashion. However, other Start events such as the onset of
DNA replication and budding are similarly delayed in both types of mutants. It
appears, therefore, that the normal activation of the G1-S transcriptional program
requires only the Cln3-Cdc28 kinase (Dirick, et al. 1995). Cln1- and Cln2-Cdc28
kinases are likely to negatively regulate Sicl, an inhibitor of G1-S progression (Dirick,
et al. 1995). Sicl accumulates early in G1, and it is destroyed by ubiquitin mediated
degradation shortly before the onset of S phase (Schwob, et al. 1994). The
association of Sicl with S phase cyclin dependent kinases (Clb5 -Cdc28 and Clb6-
Cdc28) blocks DNA replication (Mendenhall 1993). Phosphorylation of Sicl by Clnl-
and Cln2-Cdc28 kinases may trigger its ubiquitin dependent proteolysis, permitting
entry into S phase (reviewed in King, et al. 1996).
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In summary, Cln3 functions as a growth sensor and activates an essential G1-
S transcriptional program once cells have reached an appropriate size. In turn, the
induced Clnl and Cln2 proteins turn on the events associated with Start including the
degradation of a potent S phase inhibitor.
Mammalian G1/S regulators
Progression from G1 into S phase in mammalian cells is associated with a
positive feedback loop controlled both at the post-transcriptional and transcriptional
level (reviewed by Sherr 1994; Sherr 1996). In analogy to budding yeast, G1 cyclins
trigger a transcription factor (E2F) that in turn activates the rapid synthesis of G1
cyclins and other essential S phase genes. The initial events require growth
stimulatory signals, but the established feedback loop is mitogen independent.
Furthermore, there are numerous inhibitory proteins that directly target the activity
of G1 cyclins and their kinase partners.
The mammalian cyclins needed for S phase include the D-type cyclins (D1, D2,
and D3), cyclin E, and cyclin A. These cyclins and their associated cyclin-dependent
kinase (cdks) partners may constitute the S phase promoting activity defined in the
mammalian cell fusions between G1 and S phase cells. Indeed, ectopic expression of
cyclins D1, E, or A shortens G1 and leads to premature entry into S phase (Ohtsubo
and Roberts 1993; Quelle, et al. 1993; Resnitzky, et al. 1994; Resnitzky, et al. 1995);
however, their functions appear to be distinct. The three D-type cyclins are rapidly
induced upon exposure to mitogens, and their assembly with kinase partners cdk4 or
cdk6 requires mitogenic signaling (Sherr 1994). Microinjection of antibodies to cyclin
D1 prevent entry into S phase when introduced into cultured cells in middle to late Gl;
injection of cyclin D1 antibodies into cells near to the G1-S boundary, however, does
not block S phase, suggesting that the D-dependent kinases execute their S phase
promoting function in G1 (Baldin, et al. 1993; Quelle, et al. 1993). In contrast, cyclin
E and cyclin A expression normally peaks at the G1-S boundary of the cell cycle and
may be dependent on the E2F transcription factor (Botz, et al. 1996; Geng, et al.
1996; Ohtani, et al. 1995; Shultze, et al. 1995). Both cyclin E and cyclin A activate
cdk2, and the inhibition of cyclin E, cyclin A, or cdk2 function prevents entry into S
phase (Girard, et al. 1991; Ohtsubo, et al. 1995; Pagano, et al. 1993; Tsai, et al. 1993).
It is thought that cyclin D-dependent kinases sense the extracellular environment
and trigger G1 progression; cyclin E-cdk2 is downstream of the events initiated by the
D-dependent kinases, and cyclin A activates cdk2 shortly after cyclin E at the onset
of S phase. In analogy to budding yeast, cyclins D and E perform Cln3-like and
Clnl,2 -like functions respectively, and the role of cyclin A is similar to that of Clb5,6.
The activity of D-dependent kinases is likely to promote S phase by inhibiting
the function of the retinoblastoma tumor suppressor gene product, RB. The D cyclins
bind directly to RB and phosphorylate RB in vitro (Ewen, et al. 1993; Kato, et al.
1993). Underphosphorylated RB inhibits exit from G1 and phosphorylation of RB
reverses the G1 arrest ability. Notably, in cells that lack functional RB, cyclin D-
dependent kinases are dispensable for entry into S phase (Lukas, et al. 1995a)
Moreover, ectopic expression of p1 6 INK4a ( a specific inhibitor of cdk4/6) causes a G1
arrest in RB-positive but not RB-negative cells (Guan, et al. 1994; Koh, et al. 1995;
Lukas, et al. 1995b; Medema, et al. 1995). These findings suggest that RB is the
principal substrate of cyclin D-cdk4, cdk6.
The "cyclin D-RB" pathway is likely to be of physiological significance.
Inactivating mutations of the RB gene exist in a variety of human tumors. Many
tumor cells overexpress cyclin D1, leading to the phosphorylation and functional
inactivation of RB. Notably, only one component of the "cyclin D-RB" pathway is
altered in tumor cells, suggesting a functional interdependence (Sherr 1996). In
addition, transgenic mice lacking cyclin D1 function have phenotypes consistent with
cyclin D1 being a positive regulator of G1 progression (Fantl, et al. 1995; Sicinski, et
al. 1995). In D1 - /- mice, retinal cell proliferation is reduced and the breast
epithelium fails to undergo the massive steroid-induced proliferation associated with
pregnancy. The retinal phenotype is striking in that inactivating mutations in the
human RB gene cause retinoblastoma.
Several lines of evidence indicate that cyclin E-cdk2 also participates in RB
phosphorylation. Ectopic cyclin E expression in human cells causes RB
phosphorylation (Hinds, et al. 1992). In addition, cell cycle-dependent
phosphorylation of RB is reproduced when RB is ectopically expressed in budding
yeast cells. Phosphorylation of RB requires Cln3 and either Clnl or Cln2;
mammalian cyclin D1 can completely complement loss of Cln3, and cyclin E can
replace Clnl/Cln2 (Hatakeyama, et al. 1994). This suggests that the D-type cyclins
and cyclin E may collaborate in RB phosphorylation. However, it is likely that cyclin
E-cdk2 has other critical substrates. In contrast to the D-type cyclins, cyclin E is
essential for the G1-S transition in RB-positive and RB-negative cells (Ohtsubo, et al.
1995). In addition, it has been shown that ectopic expression of cyclin E, but not
cyclin D1, can override a G1 arrest imposed either by p16INK4a (cdk4/cdk6 inhibitor) or
by an RB mutant lacking conserved cdk phosphorylation sites (Lukas, et al. 1997).
Thus, cyclin E is involved in S phase promoting events that are downstream of RB
phosphorylation.
The E2F transcription factor, a heterodimer of E2F and DP proteins, is a major
target of RB action. Hypophosphorylated RB associates with and negatively
regulates the activity of E2F (Weinberg 1995). E2F-binding sites are found in the
promoters of genes that are required for DNA synthesis and those that regulate S
phase entry (Nevins 1992). E2F tethers RB to E2F-dependent promoters during G1,
and RB actively represses transcription at these promoters, suggesting that RB-E2F
complexes may suppress G1 progression. RB phosphorylation in middle to late G1
releases E2F-binding sites from RB-mediated transcriptional repression, and may
also allow E2F to act as a transcriptional activator at these sites (Qin, et al. 1995;
Weintraub, et al. 1995; Weintraub, et al. 1992). Initial RB phosphorylation is likely
to be triggered by cyclin D associated kinases in response to mitogenic signals (due to
both the timing of cyclin D-cdk function and its strict dependence on RB). During the
G1-S transition cyclin E and cyclin A, also rate-limiting for S phase entry, and are
likely to take over phosphorylation of RB (for review see Bartek, et al. 1996).
Because the genes encoding cyclin E and E2F-1 itself are E2F-dependent, a positive
feedback loop may ensue (Botz, et al. 1996; Geng, et al. 1996; Johnson, et al. 1994;
Ohtani, et al. 1995). The rapid increase in liberated E2F is thought to result in an
irrevocable commitment to enter S phase and to proliferate (Sherr 1996).
Numerous studies in mammalian cell lines implicate E2F as a critical
regulator of G1-S progression. However, it is not clear whether the predominant role
of E2F in vivo is to advance cells into S phase or suppress G1 progression. Ectopic
expression of the best characterized E2F protein, E2F-1, is sufficient to drive serum
starved, quiescent fibroblasts through G1 and into S phase, suggesting that E2F is a
potent activator of G1-S progression (Johnson, et al. 1993; Qin, et al. 1994). In
addition, it was shown that the induction of DNA synthesis by E2F-1 is dependent on
its transcriptional activation domain (Hsieh, et al. 1997; Phillips, et al. 1997; Qin, et
al. 1995). Furthermore, overexpression of dominant negative DP-1 mutant results in
a G1 arrest (Wu, et al. 1996). These findings indicate that E2F-1 may be a
transcriptional activator of G1-S progression in normal cells.
Mice lacking functional E2F-1 exhibit phenotypes that are opposite of those
predicted by the overexpression studies. Instead of defects indicative of a failure to
proliferate, the E2F-1 knockout mice develop a variety of tumors, suggesting a tumor
suppressor function (Field, et al. 1996; Yamasaki, et al. 1996). E2F-1 appears either
not to be critical for entry into S phase or other E2F proteins (E2F-2 through -5) can
compensate for this function. The primary role of E2F-1, therefore, may be to tether
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RB to E2F-dependent promoters and to repress their utilization during G1. Recent
studies suggest that RB can affect the state of chromatin condensation though an
interaction with a histone deacetylase, and already bound E2Fs may serve as docking
sites (Brehm, et al. 1998; Luo, et al. 1998; Magnaghi-Jaulin, et al. 1998).
Once cells enter S phase, cyclin A-cdk2 phosphorylates DP-1, thereby
precluding E2F from binding to DNA. The timely dissociation of E2F from E2F-
dependent promoters appears to be important for S phase progression, since
inappropriate binding of E2F to DNA (due to a failure to interact with cyclin A)
causes S phase arrest (Krek, et al. 1995). The mechanism by which E2F blocks S
phase is not understood, and it is not clear that this ability is utilized by normal cells
to control DNA replication.
S phase regulation in Drosophila embryos
Drosophila homologues of key mammalian G1-S regulators have been
identified, suggesting that the regulatory mechanisms may be conserved. These
homologues include G1 cyclins D and E, cdks 2 and 4, cyclin-dependent kinase
inhibitor p21 (dacapo), cyclin A, an RB-like protein (RBF), and both the E2F and DP
subunits of the E2F transcription factor (de Nooij, et al. 1996; Du, et al. 1996;
Dynlacht, et al. 1994; Finley, et al. 1996; Hao, et al. 1995; Knoblich, et al. 1994; Lane,
et al. 1996; Lehner and O'Farrell 1989; Ohtani and Nevins 1994; Richardson, et al.
1993; Sauer, et al. 1995; Sauer, et al. 1996). Mutations in some of these genes have
been reported and provide important insights into their in vivo functions during the
course of development.
Transcriptional regulation of S phase appears not to be important in early
embryos. Drosophila development begins with 13 extremely rapid, synchronous S-M
cycles that lack both gap phases. These nuclear divisions occur in a syncytium and
depend on maternally supplied mRNAs and proteins. The rapidity of the cycles
precludes zygotic transcription. During cycle 14 cellularization takes place, a G2
phase is added to the cell cycle, and zygotic gene expression occurs. Mitotic divisions
are no longer synchronous and groups of cells that differentiate into the same tissue
undergo mitosis as a domain (Foe 1989). These divisions are preceded by
developmentally-induced transcription of the Drosophila string gene (cdc25), a rate
limiting activator of cdc2 (Edgar, et al. 1994; Edgar and O'Farrell 1990). In contrast,
the expression of replication functions is not developmentally regulated, and S phase
immediately follows mitosis, suggesting that post-transcriptional mechanisms
continue to control the initiation of S phase.
After mitosisl6, a G1 phase is observed for the first time in Drosophila
embryogenesis. The addition of G1 correlates with the onset of a major cell cycle
divergence. The cells in the epidermis exit from the cell cycle and arrest in G1. The
embryonic precursors to the polytene larval tissues also arrest in G1 and then,
initiate the endo cell cycle in invariable tissue-specific domains (Smith and Orr-
Weaver 1991). In contrast, the embryonic neural cells continue to undergo mitotic
divisions. These developmental changes are reflected in the transcriptional regulation
of cyclin E and genes encoding replication functions: proliferating cell nuclear antigen
(PCNA), ribonucleotide reductase 1 (RNR1), RNR2, and pola (Duronio and O'Farrell
1994). During cycles 14-16, these genes are expressed at constitutively high levels.
After mitosis 16, expression is down-regulated in all tissues with the exception of the
nervous system, and transcripts accumulate prior to the onset of S phase in the endo
cycle. The spatio-temporal pattern of endo cycle S phase and the anticipatory
transcription of S phase genes are controlled by developmental inputs rather than
cell cycle progress (Duronio and O'Farrell 1994; Smith and Orr-Weaver 1991). In
string mutant embryos, the dynamic expression pattern of S phase genes (including
cyclin E) and the subsequent endo cycle S phases occur normally, even though the
preceding mitotic cycles (14-16) do not occur.
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Mutations in the cyclin E gene block S phase after mitosis 16, and ectopic
cyclin E expression is sufficient to trigger S phase in vivo (Duronio and O'Farrell 1994;
Knoblich, et al. 1994). It appears, therefore, that cyclin E is both needed and rate-
liming for DNA replication in mitotic and endo cycle cells. It is likely that cyclin E is
needed prior to cycle 16 as well, but that maternal stockpiles of cyclin E transcript
and/or protein suffice (Richardson, et al. 1993). Mutations in the gene encoding the
catalytic partner of cyclin E, cdk2 (encoded by the cdc2c gene), have not been
reported. However, Drosophila cdk2 and cyclin E form an active kinase complex
(Knoblich, et al. 1994; Sauer, et al. 1995). Thus, the block to S phase in the cyclin E
mutant is likely to result from loss of cdk2/cyclin E function.
In analogy to mammalian cells, Drosophila p21 (encoded by dacapo) has been
shown to inhibit the in vitro kinase activity of human and Drosophila cyclin E-cdk2
complexes (de Nooij, et al. 1996; Lane, et al. 1996). Indeed, strong mutations in
dacapo or ectopic cyclin E expression cause the normally G1 arrested epidermal cells
to undergo an inappropriate round of S phase. Thus, it appears that the down-
regulation ofcyclin E levels after the first 16 cycles and the inhibition of residual
cyclin E-cdk2 activity by p21 contribute to G1 arrest. This is also consistent with the
induction of dacapo transcripts and protein in epidermal cells as they exit from the
cell cycle.
The identification of Drosophila E2F and RBF (an RB-related protein) as well
as their biochemical properties provide further evidence of the similarity between the
G1-S pathway in flies and mammals. RBF has been shown to associate with
E2F/DP, and it inhibits E2F/DP dependent transcriptional activation (Du, et al.
1996). In addition, RBF can be phosphorylated by the cyclin E-cdk2 kinase in vitro
(Du, et al. 1996). The in vivo function of RBF remains unclear as the phenotypic
consequences of disrupting RBF function have not been reported. However, ectopic
expression of dE2F and dDP in embryos results in the induction of S phase genes and
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causes normally quiescent cells to enter S phase (Duronio, et al. 1996). In wild-type
embryos dE2F is required for the G1-S expression of cyclin E, PCNA, and RNR2;
these transcripts are missing in the mitotic and endo cycle tissues of dE2F mutants
(Duronio and O'Farrell 1995; Duronio, et al. 1995). This effect is likely to be direct,
since E2F binding sites have been found in the promoters of Drosophila PCNA and
pola genes (Ohtani and Nevins 1994; Yamaguchi, et al. 1995). My study reports
mutations in dDP and dE2F (including a mutation lacking the conserved C-terminal
transcriptional activation and RB-binding domain of dE2F) and explores the impact
of dE2F dependent transcription on S phase entry and development.
S phase control during Drosophila oogenesis
The mechanisms controlling S phase entry in mitotic and polyploid cells are
being rapidly revealed. In contrast, very little has been learned about the regulation
of origin activity during S phase. In a variety of systems, cytological and molecular
analyses suggest that not all origins are active within a particular round of S phase.
In addition, it is clear that different origins initiate replication at different times in S
phase. The timing of origin activation appears to be affected by chromosomal
context and gene expression. These observations suggest that developmental inputs
may determine the timing and choice of replication origins (reviewed by Fangman and
Brewer 1992).
Studies in Drosophila reveal that the regulation of origin activity during S
phase becomes increasingly complex as development proceeds and cells differentiate
(see Spradling and Orr-Weaver 1987). In early Drosophila embryos the entire S-M
cycle is completed in 8-10 minutes, with S phase being approximately 3.4 minutes
long. To duplicate the entire genome in 3.4 minutes, origins are closely spaced and
activated simultaneously at the start of S phase (Blumenthal, et al. 1973). Similar
results were reported from studies of DNA replication in other dipterans (Lee and
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Pavan 1974; Zakian 1976). At the onset of cellularization and full-blown zygotic
transcription in Drosophila embryos, the cell cycle and S phase are greatly
lengthened with S phase being 20 minutes long during cycle 14 (McKnight and Miller
1976; McKnight and Miller 1977). The longer S phase is likely to result from the
appearance of asynchrony in the activation of origins. The switch to temporal
regulation of origin activity is attributed to global changes in chromosome structure
at the time of zygotic transcription. In addition, the number of origins utilized during
S phase may decrease when heterochromatin is formed. Studies of DNA replication
in Xenopus embryos reveal that the zone where replication is initiated becomes
restricted during the mid-blastula transition, the onset of zygotic transcription
(Hyrien, et al. 1995).
In Drosophila larval brain cells (diploid mitotic tissue) there is a dramatic
reduction in the number of origins used, and it takes approximately 10-12 hours to
duplicate the genome (Spradling and Orr-Weaver 1987). The elongation rates,
however, are similar to those observed in embryos. Moreover, heterochromatic
regions replicate late in S phase. Studies of DNA replication in larval polytene cells
also reveal that replication occurs in a discrete temporal and spatial pattern:
euchromatic sequences are replicated in early to middle S phase, and
heterochromatic sequences replicate in middle to late S phase. In addition, polytene
cells underrepresent 20-30% of DNA due to incomplete replication of
heterochromatin (Hammond and Laird 1985a; Lilly and Spradling 1996; Rudkin
1969). Early and late replicating domains are also observed in yeast and mammalian
cells (McCarroll and Fangman 1988; O'Keefe, et al. 1992), suggesting that the
temporal and spatial control of origin activity is a conserved feature of eukaryotic
replication.
The Drosophila ovary is a useful tissue to identify the genes involved in
differential replication control. There are only a few cell types and their behavior is
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well characterized. Phenotypic analysis is facilitated both by the depletion of
maternal pools of most cell cycle regulators and components of the DNA replication
machinery in the adult as well as assays to monitor the parameters of replication in
situ. This is in contrast to the embryo and larva where maternally supplied wild-type
messages and products persist, making it difficult to define mutant phenotypes
precisely. In addition to the depletion of maternal products in the adult, the intensive
preparatory events for embryogenesis that occur in the ovary (polyploidization and
amplification of chorion gene clusters) place great demands on replication factors.
Weak alleles of essential functions for replication cause cell cycle defects in oogenesis,
resulting in sterility. Hypomorphic mutations in cyclin E, PCNA, and orc2 are all
female sterile (Henderson, et al. 1994; Landis, et al. 1997; Lilly and Spradling 1996).
Oogenesis begins with four mitotic divisions that produce a 16 cell egg chamber
cyst. The process of cytokinesis is incomplete, so the 16 cells are interconnected by
cytoplasmic bridges known as ring canals. These cells subsequently enter a long S
phase (24 hours or more) (Spradling 1993). This constitutes the premeiotic S phase
of the future oocyte, and as in other organisms, this replication event requires the
most time. Autoradiography studies suggest that premeiotic S phase is also
temporally regulated: euchromatin replicates first, then replication of euchromatin
and heterochromatin overlap, followed by labeling only within heterochromatin
(Carpenter 1981). Only one of the 16 cells continues through meiosis and becomes
the oocyte; the other 15 cells (nurse cells) enter the endo cell cycle from G2 and grow
via polyploidization (Spradling 1993). The relationship between oocyte determination
and the cell cycle is poorly understood. However, a mutation in cyclin E causes a
nurse cell to become a second oocyte (Lilly and Spradling 1996). Thus, differential
distribution of cell cycle regulators may play a role in oocyte determination.
During polyploidization the nurse cell genome is replicated differentially and
heterochromatic sequences are underrepresented (see Spradling and Orr-Weaver
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1987). Staining with the DNA dye DAPI reveals one or a few small, intensely labeled
chromocenters (aggregates of heterochromatic sequences) in each nurse cell nucleus.
In a female sterile cyclin E mutant the size of the chromocenter is greatly increased
due to restored late replication (Lilly and Spradling 1996). The increased presence of
nurse cell heterochromatin due to partial loss of cyclin E function suggests that cyclin
E differentially regulates the activity of DNA replication origins in polyploid cells (in
addition to its general requirement for entry into S phase). It is not clear if cyclin E is
involved in temporal control of origins in diploid cells.
It has been proposed that the extent of underrepresentation in polyploid nurse
cells is determined by the length of S phase in these cells. The relative over-
replication of heterochromatic sequences in the cyclin E mutant as compared to wild-
type nurse cells may result from a longer S phase in the mutant (Lilly and Spradling
1996) If robust oscillations of cyclin E are needed to stimulate the downregulation of
S phase, S phase may be prolonged due to dampened oscillations of cyclin E protein
during the nurse cell endo cell cycles in the mutant. During the lengthened S phase,
sequences that replicate late and are not normally replicated in wild-type nurse cells
could be replicated. There is no evidence that S phase is actually prolonged in the
mutant. However, if this mechanism turns out to be correct, the role of cyclin E in
the control of differential replication would be rather indirect. A recent study shows
that cyclin E accumulates at amplification sites in follicle cell nuclei, suggesting that
cyclin E may play a direct role in the activation and/or repression of origins (Calvi, et
al. 1998). The identification of other molecules affecting nurse cell endo cycles will
help clarify the molecular mechanism underlying differential replication.
Differential replication has also been detected in ovarian follicle cells. Follicle
cells surround the developing egg chamber cyst and undergo several mitotic divisions
to generate a monolayer of approximately 1000 cells before becoming polyploid
(Spradling 1993). The follicle cells carry out 4-5 endo cycles and underrepresent late-
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replicating DNAs. The extent of underrepresentation is more severe in polyploid
follicle cells than nurse cells, suggesting that developmental inputs modulate this
process (Hammond and Laird 1985a). The difference between follicle cell and nurse
cell underrepresentation is largely due to the more complete replication of late-
replicating rDNA genes in nurse cells. This is suggestive, since nurse cell synthesize
all the rRNA of the future embryo within oogenesis.
The relationship between replication and tissue-specific function is best
exemplified in Drosophila by the amplification of chorion gene clusters in follicle cell
nuclei. Amplification is required for the rapid synthesis of the eggshell (chorion) that
protects the embryo during its first 24 hours of development. The chorion genes are
only transcribed in the follicle cells and only after multiple copies of these genes have
been generated (reviewed by Orr-Weaver 1991). Mutants shown to be defective in
amplification (by quantitative Southern blots of egg chamber DNA) cause females to
be sterile due to synthesis of thin and inadequate eggshells for their eggs (Spradling
1993).
Amplification of chorion genes has been shown to occur in two phases (Calvi, et
al. 1998). Amplification of at least one of the chorion clusters begins during the last
follicle cell endo cycles and appears to be restricted to S phase of the endo cycle. Most
amplification, however, occurs after the cessation of genomic replication. The
transition from general amplification to amplification of chorion genes is readily
observed by BrdU labeling of whole-mount ovaries. During genomic replication, BrdU
is incorporated throughout the entire follicle cell nucleus, and groups of follicle cells in
the same egg chamber undergo BrdU incorporation at different times to give an
asynchronous pattern: both labeled (S phase) and unlabeled (G phase) follicle cell
nuclei are observed. The cessation of genomic BrdU incorporation is followed by
continuous amplification of chorion genes: BrdU is incorporated in all the follicle cells
at the same time but only at four subnuclear foci. The subnuclear BrdU foci
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correspond to amplifying regions of the genome (Calvi, et al. 1998). The continuous
incorporation of BrdU at amplifying chorion clusters is consistent with several lines of
evidence showing that these genomic interval escape restriction on replication,
including the detection of clustered replication forks in EM spreads (Osheim, et al.
1988).
Summary
The transition from G1 to S phase in dividing and polyploid cells is a critical cell
cycle control point. Developmental inputs converge on S phase activators that
phosphorylate key substrates. In addition, many essential S phase genes appear to
be transcriptionally regulated and accumulate at the G1-S transition. In polyploid
cells, DNA replication occurs in the absence of mitosis. Thus, in addition to the G1-S
activities, polyploid cells must permanently shut off all aspects of mitosis. Polyploid
cells also alter the parameters of S phase such that differential replication is readily
observed. These cells allow us to evaluate the roles of S phase players in the
temporal and spatial control of replication origins within S phase.
This thesis examines the control of DNA replication in a number of different
developmental contexts. Chapter 2 presents mutations in new and known genes that
affect a G1-S transcriptional program in mitotic and/or endo cycle cells in late
Drosophila embryogenesis. In Chapter 3, mutations in dDP are presented and used
to examine the relationship between E2F-dependent G1-S transcription and S phase
onset in vivo; the role of dDP and dE2F in cell cycle progression in mitotic and
polytene tissues is described both in embryos and at later developmental stages.
Finally, Chapter 4 presents studies in polyploid cells of the adult ovary that reveal a
requirement for E2F/DP in the differential control of DNA replication origins and
developmentally-induced apoptosis.
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Chapter Two
Screen for mutations that disrupt a
G1-S transcriptional program
in late embryogenesis
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*IR worked out the method for in situ hybridization on large numbers of independent
lines, established and screened half of the second chromosome lines, screened all of
the third chromosome lines, carried out the BrdU studies and the analysis of the
mitotic mutants.
Introduction
The first detectable G1 period in Drosophila development occurs after mitosis
16 in the embryo. It is coincident with the onset of a cell cycle divergence in three
types of tissues: the epidermis exits the cell cycle, the neural and imaginal cells
continue to undergo mitotic divisions, and the cells giving rise to most of the larval
tissues initiate polytenization. Polyteny results from the endo cycle, a modified cell
cycle in which an S phase alternates with a gap phase in the absence of mitosis
(Smith and Orr-Weaver 1991). Both the onset and the parameters of the endo cycle
are regulated developmentally (Smith and Orr-Weaver 1991). The length of the G1
phase after mitosis 16 and prior to the first polytene S phase differs considerably
between tissues, resulting in a dynamic spatio-temporal pattern of DNA synthesis.
The duration of endo cycle gap phases and the final levels of polytenization also vary
from tissue to tissue in a stereotypic manner.
It has long been thought that the switch from a mitotic cell cycle to
polytenization requires at least one global regulator controlling the onset of
endoreplication in all polytene tissues. In addition, multiple tissue-specific regulators
of endoreplication may exist. To date, however, mutations in genes specific for the
onset of polytene replication have not been isolated. 34% of the Drosophila genome
has been screened for loci that affect DNA replication late in embryogenesis using
overlapping deficiency stocks (Smith, et al. 1993). This systematic search for S
phase regulators yielded no endo cycle specific functions, but three intervals affecting
replication in polytene and diploid tissues were found. One of the intervals correlates
with the deletion of the histone genes. It is not clear whether the other two intervals
encode regulatory functions for replication or components of the replication
machinery.
To date, cyclin E is the only known regulator of the G1-S transition that is
limiting for S phase in late embryogenesis (Knoblich, et al. 1994; Richardson, et al.
42
1993). Mutations in the cyclin E gene block S phase after mitosis 16 in mitotic and
endo cycle cells (Knoblich, et al. 1994). The requirement for cyclin E function
correlates with the onset of a G1-S transcriptional program that includes cyclin E and
several other S phase genes: proliferating cell nuclear antigen (PCNA), DNA
polymerase a, and the two ribonucleotide reductase subunits (RNR1 and RNR2)
(Duronio and O'Farrell 1994). These S phase functions are expressed constitutively
prior to mitosis 16. However, upon addition of a G1 period, expression of these genes
is restricted to late G1 and S phases of the cell cycle and parallels the spatio-
temporal pattern of S phase in late Drosophila embryogenesis (Duronio and O'Farrell
1994). In analogy to other systems, we reasoned that the induction of essential S
phase genes at the G1-S boundary reflects a decision to progress through the cell
cycle. The transcriptional pattern of these S phase reporter genes, therefore, could
be used to identify genes that regulate S phase entry in mitotic and endo cycle cells.
We devised a method for doing in situ hybridizations on large numbers of
independent mutagenized lines and screened for zygotic mutations that alter the
expression of endogenous PCNA transcripts in polytene and/or mitotic tissues in late
embryogenesis. The ability to examine S phase in mitotic and polytene tissues during
the same developmental period made it possible to distinguish between regulators
specific to the endo cell cycle and a set of G1/S genes that are common to the mitotic
and endo cell cycles. PCNA was chosen as the S phase reporter in the primary
screen because it is expressed well in both mitotic and polytene tissues. The levels of
RNR2 transcripts are low in the CNS, and cyclin E transcripts are present at low
levels in the endodomains, making it difficult to examine S phase in mitotic and
polytene cells simultaneously. However, both RNR2 and cyclin E were used in
secondary screens in order to distinguish mutations specific to PCNA expression from
those that affect the coordinate expression of S phase genes at the G1-S boundary.
Mutations in genes that affect only PCNA transcription should show normal spatio-
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temporal expression of the other S phase reporters. In addition, it is important to
note that alterations in PCNA transcription would be detected only in embryos
mutated in genes for which maternal gene products do not persist late into
embryogenesis.
We expected to identify a variety of zygotic mutants in which the expression of
PCNA is affected. The mutant embryos would fall into three morphological classes:
(1) mutants with gross developmental abnormalities; (2) mutants with morphological
abnormalities suggestive of a failure to complete the postblastoderm mitotic divisions
(cycles 14-16); and (3) mutants that are morphologically normal. The majority of the
mutants were expected to fall into the first class, but their effect on PCNA expression
is likely to be indirect. The second class was expected to define essential mitotic
functions. Seven genes are known from previous work to encode products necessary
for progression through cycles 14-16: string, pimples, pebble, three rows, fizzy, cyclin A
and l(2)51Ec ( for review see Orr-Weaver 1994). We expected to recover additional
alleles of these genes as well as new genes. The third class of mutants were of
greatest interest, since mutations that block the cell cycle after mitosis 16 are
expected to be morphologically normal, an expectation that derives from the normal
appearance of cyclin E mutant embryos (Knoblich, et al. 1994). This class of
mutants should include mutations that cause a block to replication in mitotic and
polytene tissues or polytene tissues specifically.
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Results
Genetic screen
We mutagenized flies with EMS and established 3010 second chromosome
lines, each representing a single mutagenized chromosome with an average of 2.7
lethal hits (Fig. 1). In addition, 1000 third chromosome lines were provided by the
Lehmann lab (Moore, et al. 1998). The mutagenized chromosomes were maintained
over a balancer chromosome marked with a Ubx-lacZ transgene to distinguish
between embryos homozygous for the mutagenized chromosome and their
heterozygous siblings. Embryos were collected from independent mutant lines,
staged appropriately, and hybridized in situ with labeled lacZ and PCNA riboprobes
simultaneously (embryos that did not express lacZ were homozygous for the
mutagenized chromosome). Hybridizations were performed in mass in multi-well
dishes. Then, embryos from each line were mounted and examined microscopically
for alterations in endogenous PCNA expression in polytene and mitotic tissues (Fig.
2B). The embryos that were heterozygous for the mutagenized chromosomes
expressed lacZ, serving as an internal control for the efficacy of the staining reaction
(Fig. 2C). In addition, the pattern of lacZ expression did not obscure the spatio-
temporal pattern of PCNA transcripts. This made it possible to ascertain whether
the mutations were recessive or dominant.
The results from the screen of the second and third chromosome are
summarized in Table 1. The mutants were categorized into three classes: gross
morphological defects, postblastoderm defects, and morphologically normal. The
mutants with gross morphological defects were not maintained because their affect
on the pattern of PCNA transcription is likely to be indirect. The other two classes of
mutants were kept for further study. The majority of the mutants that appeared to
arrest during the mitotic postblastoderm divisions (cycles 14-16) did not affect the
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Figure 1. Screen for mutations on the second chromosome that disrupt G1-S
transcription in mitotic and/or polytene cells. The crosses to establish independent
mutagenized lines are shown. Isogenized cn bw sp males were mutagenized with EMS
and the mutagenized chromosomes were ultimately balanced over a chromosome
marked with a Ubx-lacZ transgene. From the F3 adults, 8- to 15-hr embryos were
collected and hybridized in situ with PCNA and lacZ riboprobes. Mutant lines that
produced embryos with altered PCNA expression or that had morphological defects
consistent with an arrest during cycles 14-16 were maintained for further analysis.
DTS91 pr cn
P[Ubx-lacZ]CyO
DTS91 pr cn
P[Ubx-lacZ]CyO
EMS
cn bw sp d'd'
cn bw sp
(cn bw sp)*
P[Ubx-lacZ]CyO
single d'
(cn bw sp)*
DTS91 pr cn
29' 4 days
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(cn bw sp) *
P[Ubx-lacZ]CyO
(cn bw sp)*
P[Ubx-lacZ]CyO
99 + di'
Collect embryos and examine by in situ hybridization.
Fl:
F2:
F3:
Figure 2. PCNA expression was used as the reporter in a genetic screen.
(A) The spatio-temporal pattern of DNA replication is shown in a wild-type 10.5-
hr embryo. The darkly staining cells are those that incorporated BrdU during a 40-
min pulse. The mitotically proliferating central nervous system (CNS), the
endoreplicating anterior midgut (amg), central midgut (cmg), posterior midgut (pmg),
hindgut (hg), and malphigian tubules (mt) incorporate BrdU.
(B) The transcription pattern of PCNA precisely matches the spatio-temporal pattern
of BrdU incorporation. PCNA transcripts were detected by whole-mount in situ
hybridization. A wild-type 10.5-hr embryo is shown.
(C) A 10.5-hr embryo from a wild-type line maintained over a balancer chromosome
marked with a Ubx-lacZ transgene is shown. Both PCNA and lacZ transcripts were
detected in heterozygous embryos by whole-mount in situ hybridization. LacZ
expression is observed in the posterior half of the embryo (right) in the epidermis
and does not obscure the expression of PCNA in the endodomains.
Table 1: Results from in situ hybridization screen
Lines scored
Lines selected
Morphological Classes:
gross abnormalities
post blastoderm defects
normal morphology
second chromosome
3010
160
third chromosome
1000
15
137
12 3
expression of PCNA. These mutations were maintained because they may provide
insight into the regulation of mitosis. However, four mutations with morphology
indicative of a failure to progress through the three postblastoderm divisions did
affect the expression of PCNA. These mutations are likely to be needed for
replication during cycles 14-16. In twelve of the mutagenized second chromosome
lines and three third chromosome lines, PCNA expression was altered but the
morphology of the homozygous mutant embryos was normal (Table 1). These
mutations are of greatest interest because they control PCNA transcription at a
developmental stage when most tissues initiate endo cycles.
Morphologically normal mutants
Seven of the second chromosome lines failed to express PCNA transcripts in
mitotic and polytene tissues at wild-type levels (Fig. 3B,C). These lines had similar
effects on RNR2 expression and showed a reduction in the levels of the cyclin E
transcripts in the endodomains. The expression of PCNA in five of the mutations was
almost identical to that previously described for mutations in the dE2F gene (Fig. 3B)
(Duronio, et al. 1995). Given the similarity between the dE2F phenotype and that of
our mutants, we tested whether a deficiency known to delete the dDP gene also
uncovered these five mutants. All five mutations failed to complement the dDP
deletion. The position and nature of the dDP mutations was determined and is shown
in Chapter 3. These five mutations provide the first opportunity to examine the in
vivo role of this gene (see Chapters 3 and 4). The other two mutations constitute a
complementation group that appears to be novel.
Five mutations failed to downregulate the expression of PCNA in the
endodomains (Fig. 3D). PCNA transcription is activated normally, but the
transcripts persist inappropriately. This phenotype was observed previously for
cyclin E (Duronio and O'Farrell 1995; Sauer, et al. 1995), and all five mutations failed
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Figure 3. PCNA expression in mutant embryos with normal morphology.
PCNA transcripts were detected by whole-mount in situ hybridization.
(A) PCNA transcripts in a wild-type 10.5-hr embryo.
(B) PCNA is expressed at greatly reduced levels in the central nervous system
(CNS) and the endodomains of 10b (dDPa4 ) homozygous mutant embryos. This
complementation group is the Drosophila DP gene (5 alleles).
(C) PCNA transcripts are diminished especially in the endodomains of 3.47
mutant embryos (2 alleles), but not to the degree observed in the dDP mutants.
(D) PCNA transcripts are not downregulated in the endodomains of 32a
homozygous mutant embryos. The continued presence of PCNA transcripts in
the salivary gland (arrow) is inappropriate for this developmental point. This
mutation and four others fail to complement the cyclin E gene. In the allele
being shown the cells in the CNS are larger than normal and possibly polyploid.
(E) PCNA expression is specifically off in endo cycle cells of 1q19 (dE2Fi l)
mutant embryos. This mutation and one other are new alleles of dE2F.
to complement each other and strong mutations in the cyclin E gene. Allelism was
determined based on the failure to recover transheterozygous viable progeny as well
as the failure to downregulate PCNA transcription in the endodomains of
transheterozygous embryos. All five of the mutations are lethal in trans to strong
alleles of cyclin E. However, one of the mutations (1f36) appears to be weaker than
the others. In addition, one of the putative cyclin E alleles (32a) has enlarged cells in
the CNS and may provide new insights into the activity of cyclin E, if this phenotype
is indeed linked to the putative cyclin E mutation. The replication phenotypes of 32a
and the other new alleles could be informative.
From the third chromosome lines, two mutants were recovered with reduced
levels of PCNA expression in polytene tissues (Fig. 3E). This mutant phenotype was
predicted for an endo cycle specific regulator. These two mutations fully complement
each other. However, the transheterozygous embryos were not examined by in situ
hybridization. To our surprise, both mutations affect the dE2F gene (see Chapter 4),
although dE2F is essential in both mitotic and polytene tissues (see Chapter 3). One
of the new dE2F alleles is fully viable in trans to a dE2F deficiency. The other
mutation is semi-lethal. We also recovered a third chromosome mutant line that
affects PCNA expression in mitotic and polytene tissues. This may be another allele
of dE2F or a new gene.
Postblastoderm mutants
In addition to the mutants discussed above, a number of known and novel
genes that are required during the mitotic postblastoderm divisions (cycles 14-16)
were isolated. These mutants were readily identified due to the characteristic small
size of the embryos and neural cells that appear polyploid (Fig. 4 A,B). Seven of the
mutated second chromosome lines were tested for lethality in trans to fizzy, three
rows, and pimples. These complementation tests revealed that two of the lines failed
Figure 4. PCNA expression in mutants that are arrested during cycles 14-16.
PCNA transcripts were detected by whole-mount in situ hybridization.
(A) In this 10.5 hr homozygous mutant embryo (249), PCNA is expressed in the
normal pattern but the embryo is smaller and the cells in the central nervous
system become polyploid. This mutation fails to complement alleles of pimples,
a gene that acts in mitosis to promote the separation of sister chromatids
(Stratmann and Lehner, 1996).
(B) A ventral view of a homozygous mutant embryo from the line shown in A.
The defect in the nervous system is very distinct; this class of mutants were
therefore readily identified in this screen.
(C) In this homozygous mutant embryo (19K), PCNA transcripts persist
inappropriately in the epidermis. This mutation is part of the l(2)51Ec
complementation group and there are three other new alleles.
(D) A 10.5 hr homozygous mutant embryo is shown from the same line (19K).
The epidermal PCNA expression is reduced and the normal spatio-temporal
pattern of PCNA transcription can be seen in the endodomains.
to complement pimples and another line failed to complement three rows. Both
pimples and three rows act in mitosis to promote the separation of sister chromatids
((Stratmann and Lehner 1996). The mutants fail to undergo cytokinesis, and as a
consequence the neural cell are greatly enlarged. The other four lines complement
each other and may define several new functions required during cycles 14-16. From
the third chromosome lines, one line appears to be arrested during cycles 14-16. This
mutation is likely to define a new gene since there are no third chromosome
mutations known to affect the postblastoderm divisions.
We also isolated four second chromosome mutations that arrest during cycles
14-16 but appear to affect replication rather than chromosome segregation. These
four mutations fail to complement each other and 1(2)51Ec. 1(2)51Ec has already
been identified as having a replication phenotype during the postblastoderm divisions
(Smith, et al. 1993). The new mutants and l(2)51Ec fail to downregulate constitutive
transcription of S phase genes in the epidermis (Fig. 4C). Developmentally regulated
G1-S transcription in endo cycle tissues was observed in the correct pattern (Fig. 4D).
In addition, DNA replication, as gauged by incorporation of BrdU, seems to persist in
the normally arrested epidermis after mitosis 16 (compare Fig. 5B to 5A). The BrdU
labeling was punctate and did not fill the entire nucleus (compare Fig. 5B' to 5A').
This staining pattern is suggestive of continued late replication of S phase 15 or 16
rather than a new round of S phase. In the endodomains DNA replication was mostly
blocked (Fig. 5B).
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Figure 5. In the 1(2)51Ec complementation group DNA replication persists in
the normally arrested epidermis.
DNA replication was assayed by BrdU and shown for 10.5-hr embryos labeled
for 40-min followed by antibody staining detected by the horseradish peroxidase
(HRP) reaction. The darkly staining cells are those that incorporated BrdU
during the pulse.
Panels A and B are at the same magnification and are shown below (A' and B')
at a higher magnification. The focus is on the epidermis.
(A-A') BrdU incorporation is shown in a wild-type embryo. Note that BrdU
labeling fills the entire nucleus.
(B-B') Inappropriate BrdU incorporation is observed in the epidermis of 1(2)5lEc
homozygous mutant embryos. BrdU labeling is not uniform throughout the
nucleus. Note that the labeling is greatly diminished as compared to wild type
except for an intensely staining region (arrow) of the nucleus. This punctate
pattern of BrdU incorporation is indicative of late replication. DNA replication
in the endodomains is mostly blocked.
Discussion
The in situ hybridization screen, although labor intensive, has proved to be
very successful. The ability to visualize a G1-S transcriptional program in mitotic
and endo cycle cells allowed us to isolate both known and novel functions (Table 2).
All predicted classes of mutants were identified by this approach. In addition, the
types of mutants that were isolated testifies to the specificity of the screen. The
screen on the second chromosome was comprehensive. Nearly 9000 lethal
mutations (3010 X 2.7) were examined on the second chromosome. The
completeness of the screen is also suggested by the number of alleles that compose
each complementation group: five for cyclin E, five for dDP, four for l(2)51Ec. There
are two loci (dDP and novel) that are needed for G1-S transcription in mitotic and
polytene cells. All mutations that result in a failure to downregulate the G1-S
transcriptional program in endodomains define a single complementation group
(cyclin E). One gene, 1(2)51Ec, becomes essential for replication during cycles 14-16.
It is possible that we identified all the genes on the second chromosome that regulate
the decision to enter S phase. In contrast, the third chromosome screen was not
exhaustive. However, it led to the identification of two very interesting alleles of
dE2F.
It still remains unclear what is required to break the dependence of S phase
and mitosis in polytene cells. A mutation specifically affecting the transcription of
PCNA in all polytene tissues was not recovered on the second chromosome. It is
likely, therefore, that a global control necessary for the onset of polytenization is not
found on the second chromosome or its function is supplied by maternal contributions
of wild-type product. Two mutations on the third chromosome reduce PCNA
transcription specifically in endo cycle cells. Both mutations are in the dE2F gene.
Further analyses have shown that these new mutations may not be strictly endo
cycle specific although most of the defects are observed in polyploid cells (Chapter 4).
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Table 2: Summary of mutants from in situ hybridization screen
second chromosome
Postblastoderm mutants:
1(2)51Ec
pimples
three rows
four novel genes
one novel gene
Morphologically normal mutants:
dDP
one novel(3.47) gene
cyclin E
dE2F
one novel gene
third chromosome
4 alleles
2 alleles
1 allele
1 allele/each
1 allele
5 alleles
2 alleles
5 alleles
2 alleles
1 allele
_ I __ I I I I I I I I I~ I I
A global regulator of the endo cell cycle may be identified from a more complete
screen on the third chromosome and/or a similar screen on the X chromosome. It is
also possible that the downregulation of mitotic functions is sufficient to convert a
mitotic cycle into an endo cell cycle. If that is the case, a mutation in a gene that
controls the switch to an endo cell cycle would result in ectopic mitotic events (e.g.
spindle formation and condensed chromosomes) in cells that are normally polytene.
It is not clear that the presence of ectopic spindles would disrupt the G1-S
transcriptional program. Therefore, loss of a critical endo-specific function may not
be detected by our approach.
The mutants identified in this screen allow the in vivo role of known cell cycle
regulators to be evaluated and provide insights into the regulation of replication in
polytene and mitotic cells. In addition to the mutations in dDP, a novel
complementation group on the second chromosome appears to be required for the
induction of G1-S transcription in mitotic and polytene tissues after mitosis 16. This
complementation group may turn out to regulate the G1-S transition. This group
needs to be mapped genetically, and the cytological location can then be determined
by performing complementation tests with second chromosome deficiencies.
Deficiencies can also be used to assess whether the mutations are hypomorphs or
nulls. The mutations are likely to be weak, because the levels of S phase transcripts
were not dramatically reduced in either of the mutant lines. Further phenotypic
analysis can be pursued once a deficiency or a strong allele is isolated.
1(2)51Ec becomes limiting for replication during the postblastoderm divisions.
Further characterization and the cloning of 1(2)51Ec will help to determine the role of
this gene in replication. At this point, it is not clear whether the failure to
downregulate G1-S transcription in the epidermis is the cause or the consequence of
the replication defect during cycles 14-16. It is possible that in the 1(2)51Ec mutants,
existing S phase transcripts are stabilized or constitutively transcribed due to a
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failure to progress through S phase. Thus, persisting transcripts may be a secondary
consequence of the S phase arrest. A similar situation may occur in the cyclin E
mutants. In the cyclin E mutants, S phase is blocked after cycle 16 (Knoblich, et al.
1994). S phase genes including cyclin E are transcribed in the normal spatio-
temporal pattern but then persist inappropriately (Duronio and O'Farrell 1995;
Sauer, et al. 1995). It has been suggested that cyclin E is actively involved in down-
regulating its own transcription as well as that of other S phase genes ( PCNA and
RNR2). However, it is possible that the block to S phase progression in cyclin E
mutants may be responsible for the failure to extinguish the expression of S phase
genes. It is clear both from 1(2)5lEc and the cyclin E mutants that the activation of
S phase genes in the correct developmental pattern is not dependent on S phase.
Thus, if the decision to progress from G1 into S phase is reflected by the associated
G1-S transcriptional program, then 1(2)51Ec and cyclin E act downstream of these
events.
The new mitotic mutants isolated in this screen may also prove to be very
interesting. The new genes are likely to provide further insight into the regulation of
the metaphase/anaphase transition in mitotic cells. In addition, functions that
promote exit from mitosis may also be involved in repressing mitotic activities in endo
cycle cells.
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Materials and Methods
Fly strains
The cn bw sp and DTS91 stocks were provided by R. Lehmann (Skirball
Institute, New York University Medical Center, New York, NY). The Ubx-lacZ CyO
chromosome has been described previously (McCall, et al. 1994).
EMS mutagenesis and genetic screen
See Figure 1 for an outline of the screen. Isogenized cn bw sp males were
mutagenized with a 35mM EMS solution (Sigma) in 1% sucrose for 24 hours. The
males were then mated to DTS91 pr cn / P[Ubx-lacZ] CyO virgin females. Male
progeny from this cross were mated singly to DTS91 pr cn / P[Ubx-lacZ] CyO virgin
females. The dominant temperature-sensitive lethal mutation (DTS91) chromosome
was used to select for flies bearing the mutagenized chromosome over the P[Ubx-
lacZ] CyO balancer. The crosses were placed at 29oC, the restrictive temperature
for the DTS91 mutation, for three days. Then, the adults were removed, and the vials
were incubated at 2900 for an additional day before being moved to 25 0C. cn bw sp /
P[Ubx-lacZ] CyO females and males from this cross were selected and mated to
establish mutant lines. 8-15 hour embryos were collected from these lines and
hybridized simultaneously with PCNA and lacZ riboprobes.
In situ hybridization procedure
In situ hybridizations were performed on 144 independent mutagenized lines
at a time. Embryos were collected from mutant lines using the block method
(Niisslein-Volhard, et al. 1984) and staged appropriately (8-15hr). To obtain eggs
from 144 mutant lines eight collection blocks (18 lines each, 10-15 flies per line) were
set up before each experiment. It usually took 2-3 days for the flies to adjust to the
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collection blocks and to begin to lay eggs well. Three collections from each block were
needed to obtain enough embryos from each line to score for the affect on PCNA
expression. The collections were carried out over a period of three days. The eggs
from the first and second day where kept at 40C until the last collection was ready.
Then eggs were transferred from the apple juice agar plates into four 36-well staining
dishes. Each well had three sets of egg collections from a single mutagenized line.
All the steps to prepare embryos for in situ hybridization were carried out in
the 36-well dishes. The embryos were washed in water three times, dechorionated for
5 min in 50% bleach, washed three times in water, and fixed with gentle shaking in 1:1
heptane:12% paraformaldehyde in PBS. Embryos were then washed twice in
heptane briefly. To devitellinize the embryos an equal volume of heptane and
methanol were added followed by vigorous shaking for four minutes. The embryos
were then washed in methanol several times to remove all traces of heptane. The
devitellinized embryos sank to the bottom and the non-devitellinized embryos were
removed from the top by aspiration. The remaining embryos were rehydrated and
subject to in situ hybridization.
Digoxygenin-labeled antisense riboprobes were made according to the
Boehringer Mannheim kit. In situ hybridization was carried out essentially as
described (Tautz and Pfeifle 1989) with a few key modifications to reduce the levels of
background due to the use of the multi-well staining dishes. The fixation after the
proteinase K treatment was done for 20 min in 8% paraformaldehyde in PBS.
Hybridization was carried out at 650C. 1% sheep serum was added to incubation
with the anti-digoxygenin antibody conjugate (Boehringer Mannheim) used at 1:4000
in PBT (PBS/.05% Tween 20). After the embryos were stained, the embryos from
each well were transferred into an eppendorf tube and mounted in 70% Glycerol: 30%
PBS. Each line was then examined microscopically for changes in the PCNA
transcription pattern.
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BrdU labeling of embryos
Embryos were collected from mutagenized stocks for seven hours at 25 0C and
aged for 12 hours at 180C (this is equivalent to 8 hours at 250C). The resulting 8-
15hr collection of embryos was then permeabilized with octane and labeled with
BrdU. These and subsequent steps were carried out essentially as described
previously (Bodmer, et al. 1989). The embryos were incubated with BrdU for 40 min.
at room temperature while shaking in a scintillation vial. After fixation, the embryos
were hydrolyzed in 2N HC1 for 70 min. The length of the HCI treatment is important
for good detection of BrdU incorporation. An anti-B-galactosidase antibody was used
along with the anti-BrdU antibody. The anti- B-galactosidase antibody allows the
25% homozygous mutant embryos to be distinguished from their siblings (the
heterozygotes express lacZ from the Ubx-lacZ transgene on the balancer
chromosome). The antibody staining was detected using the horseradish peroxidase
histochemical reaction.
Microscropy
A Zeiss Axiophot microscope equipped with Nomarski optics was used to
examine and photograph the embryos using Plan-Neofluar 10X, 20X, and 40X
objectives.
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Abstract
The E2F transcription factor, a heterodimer of E2F and DP subunits, is
capable of driving the G1-S transition of the cell cycle. However, mice in which the
E2F-1 gene had been disrupted developed tumors, suggesting a negative role for E2F
in controlling cell proliferation in some tissues. The consequences of disrupting the DP
genes have not been reported. We screened for mutations that disrupt G1-S
transcription late in Drosophila embryogenesis and identified five mutations in the
dDP gene. Although mutations in dDP or dE2F nearly eliminate E2F-dependent G1-
S transcription, S phase still occurs. Cyclin E has been shown to be essential for S
phase in late embryogenesis, but in dDP and dE2F mutants the peaks of G1-S
transcription of cyclin E are missing. Thus greatly reduced levels of cyclin E
transcript suffice for DNA replication until late in development. Both dDP and dE2F
are necessary for viability, and mutations in the genes cause lethality at the late
larval/pupal stage. The mutant phenotypes reveal that both genes promote
progression of the cell cycle.
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Introduction
The regulation of the transition between the G1 gap phase and S phase is a
critical cell cycle control point, because duplication of the DNA commits a cell to
division. This transition has been inferred to be controlled both at the
posttranscriptional and transcriptional level (Murray and Hunt 1993; Nasymth,
1996). In the yeast S. cerevisiae the activation of the CLN/CDC28 kinase complex
drives the cells into S phase, while in mammalian cells activation of the
cyclinE/CDK2 complex is crucial for the onset of DNA replication. Thus
phosphorylation of key substrates by these kinase complexes is one regulatory
component of the initiation of S phase. Regulation also appears to occur at the level
of transcription, however, because CLN 1 and 2 and cyclin E transcripts accumulate
in G1. In addition, many genes encoding proteins necessary for DNA replication are
transcribed at the onset of S phase.
E2F is a transcription factor whose activity has been linked to the G1-S
transition in mammalian cells. This transcription factor is a heterodimer of the E2F
protein and the DP protein, and there are several forms of either protein present in
mammalian cells (Weinberg 1995). E2F/DP has been shown to activate the
transcription of several genes needed for S phase, and E2F/DP binding sites are found
in the promoters of many others (Nevins 1992). In addition, E2F/DP binding may
repress the transcription of some of these genes during G1 when the heterodimer is
complexed with one of the family of pocket proteins, one member of which is pRB
(Weintraub, et al. 1995; Weintraub, et al. 1992; Zwicker, et al. 1996). E2F/DP is the
focal point of a regulatory loop that links both transcriptional and posttranscriptional
control of the cell cycle (for review see Sherr, 1996). Phosphorylation of pRB by
either the cyclinD/CDK4,6, cyclinE/CDK2, or cyclinA/ CDK2 kinases releases pRB,
possibly enabling E2F/DP to function as a transcriptional activator. Because the
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cyclin E gene itself is transcriptionally controlled by E2F/DP, a positive feedback loop
ensues (Botz, et al. 1996; Geng, et al. 1996; Ohtani, et al. 1995).
It is not clear whether in vivo E2F/DP acts primarily as a positive or negative
transcription factor or whether it plays alternate predominant roles in different types
of tissues. In addition, while the importance of transcriptional control of the onset of
S phase is inferred from its correlation with DNA replication, its significance relative
to posttranscriptional control mechanisms is not established. Overexpression of E2F
protein in mammalian cell culture drives cells into S phase (Johnson, et al. 1993;
Lukas, et al. 1996; Shan and Lee 1994). However, transgenic mice lacking a
functional E2F-1 gene exhibited phenotypes consistent with the E2F transcription
factor acting either positively or negatively in different tissues (Field, et al. 1996;
Yamasaki, et al. 1996). In these mice some tissues atrophy, but other tissues
develop tumors. The consequences of disrupting the DP genes have not been
reported.
Drosophila shares many of the components of the mammalian G1-S
regulatory circuitry. Drosophila homologs to E2F, DP, an RB-like protein (RBF),
cyclin E, CDK2, cyclin D, CDK4, and the p21 inhibitory protein (dacapo) have been
identified (de Nooij, et al. 1996; Du, et al. 1996a; Dynlacht, et al. 1994; Finley, et al.
1996; Hao, et al. 1995; Knoblich, et al. 1994; Lane, et al. 1996; Ohtani and Nevins
1994; Richardson, et al. 1993; Sauer, et al. 1995; Sauer, et al. 1996). The precise
developmental control of the onset of S phase late in Drosophila embryogenesis
makes it possible to define mutant phenotypes with high resolution and to infer the
primary defect in cell cycle regulation (Smith, et al. 1993; Smith and Orr-Weaver
1991). The first 13 divisions in the embryo occur in a rapid S-M cycle that is driven
by maternal stockpiles of cell cycle regulators (for reviews see Foe, et al. 1993; Orr-
Weaver 1994). Following cellularization and the onset of zygotic gene expression,
another three cell cycles take place with a G2 phase during which transcription
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occurs, but they lack a G1 phase. After mitosis 16, a detectable G1 phase appears
for the first time during embryogenesis, and it marks the onset of the endo cell cycle
for many of the larval tissues. In these cells S phase alternates with a gap phase,
but mitosis does not occur, leading to polyteny. During the latter half of
embryogenesis the cells that will form the polytene larval tissues undergo S phase in
a stereotypic developmental pattern. During the same developmental period the
nervous system cells continue to go through mitotic divisions.
Cyclin E is essential for S phase late in Drosophila embryogenesis (Knoblich, et
al. 1994; Sauer, et al. 1995). Mutations in cyclin E block DNA replication after
mitosis 16, coincident with the first G1 phase. Presumably cyclin E is necessary for
S phase earlier in embryogenesis but maternal stockpiles of the protein and/or
transcripts suffice (Richardson, et al. 1993). The onset of the requirement for cyclin
E correlates with a change in its transcriptional regulation (Knoblich, et al. 1994).
During the postblastoderm divisions the levels of cyclin E transcript are
constitutively high. After mitosis 16 they are downregulated in all of the tissues
except the nervous system, and transcripts accumulate prior to S phase in the endo
cycle late in embryogenesis. The same transcriptional pattern observed for cyclin E
also occurs for several genes encoding replication functions: PCNA, RNR1, RNR2,
and pol a (Duronio and O'Farrell 1994). These observations led to a model in which
transcriptional regulation is crucial in controlling the G1-S transition in the endo
cycle, with cyclin E being the critical target (Duronio and O'Farrell 1994; Duronio and
O'Farrell 1995; Sauer, et al. 1995).
In order to identify regulatory genes needed for G1-S transcription, we screened
for mutants defective in the induction of PCNA transcription late in embryogenesis.
We found five mutations in a gene essential for PCNA and RNR2 transcription and
demonstrated that these are alleles of the Drosophila DP gene. We show that the
dDP gene is essential for viability. Despite the pronounced effect on G1-S
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transcription, DNA replication still occurs and lethality is late in development. We
find that mutations in dE2F give similar phenotypes to those in dDP: E2F/DP-
dependent G1-S transcription is disrupted, but S phase takes place and the animals
survive to late larval/ early pupal stages.
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Results
Screen for genes required for S Phase transcription in the embryo
To recover genes necessary for the transcription of S phase genes late in
Drosophila embryogenesis, we directly used the trancription pattern as the assay in a
genetic screen. The PCNA and RNR2 genes were used because they are transcribed
in a pattern that mimicks that observed by BrdU labeling of late Drosophila embryos
(Duronio and O'Farrell 1994). The E2F/DP recognition sites in the PCNA promoter
are essential for its expression (Yamaguchi, et al. 1995). We devised a method for in
situ hybridization to detect transcripts on large numbers of independent mutagenized
lines. Embryos were collected from lines established from single, mutagenized second
chromosomes, aged to 8-15 hours, and hybridized in situ to a PCNA riboprobe (see
Methods, Fig. 7). This developmental stage was chosen because between 8-15 hours
there is a G1 phase with a regulated transcriptional program. In addition, S phase
transcription can be observed both in cells undergoing endo cycles as well as in the
mitotically dividing cells of the nervous system.
From 3010 mutated second chromosome lines, seven lines were recovered that
failed to express the PCNA transcript at normal levels in 8-15 hour embryos. In all of
these lines PCNA transcript was reduced in both the mitotic and endo cycle tissues.
As a secondary test, the RNR2 transcript was also affected in the mutant embryos.
Complementation tests showed that the mutants fell into two complementation
groups. One group, containing two alleles, showed a reduction in PCNA and RNR2
transcript levels. In the second group of five mutations had a stronger reduction in
PCNA or RNR2 transcripts to nearly undetectable levels late in embryogenesis. This
latter complementation group was subjected to further analysis.
Mutations in the Drosophila DP gene
The expression of PCNA and RNR2 in the strong complementation group was
almost identical to that previously described for mutations in the dE2F gene (Fig. 1)
(Duronio, et al. 1995). The one distinction was that in the new complementation
group there was a higher level of RNR2 transcript uniformly present throughout the
epidermis. This was a weak signal that gave the appearance of a higher background
in the homozygous mutant embryos (data not shown).
A homolog to the mammalian DP protein, the other subunit of the E2F
transcription factor, was identified in Drosophila (dDP) and mapped to the second
chromosome. Mutations in the dDP gene had not been identified (Hao, et al. 1995).
Given the similarity between the dE2F phenotype and that of our mutants, we tested
whether a deficiency known to delete the dDP gene also uncovered our
complementation group. All five mutations were lethal in trans to each of the three
deletions that remove dDP. Furthermore, in situ hybridization of embryos
transheterozygous for the mutation and the Df(2R)vg-B deficiency gave the mutant
phenotype, undetectable PCNA expression in late embryos.
To confirm that the mutations mapped to the dDP gene, we sequenced the dDP
gene from two of the mutant lines. Because the mutations cause pupal lethality (see
below) we were able to isolate genomic DNA from larvae transheterozygous for the
mutation and a deficiency. A region of 1400 base pairs that encompasses the regions
of the protein conserved with mammals was amplified by PCR from mutant larval
genomic DNA, and the PCR product was sequenced directly. The sequenced region
contains several important motifs, including the DNA binding region, the DEF box
which is predicted to be required for DP/E2F heterodimerization, and three other
highly homologous regions named DCB1, DCB2, and NCB (Fig. 2) (Dynlacht, et al.
1994; Hao, et al. 1995). To recognize polymorphisms between our strains and those
used for the published sequence, we also sequenced the same region from
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Figure 1. PCNA expression in dDPand dE2F mutant embryos.
PCNA transcripts were detected by whole-mount in situ hybridization.
(A) In wild-type 10.5 hour embryos PCNA is expressed in the mitotically
proliferating central nervous system (CNS), in the endoreplicating anterior
midgut (amg), central midgut (cmg), posterior midgut (pmg), hindgut (hg), and
malpighian tubules (mt).
(B) In 10.5 hour homozygous dDPa4 mutant embryos PCNA is expressed at
greatly reduced levels in the CNS and is not detectable in the endodomains.
(C) dE2F9 1 homozygous 10.5 hour embryos show a similar phenotype. In some
embryos a low level of PCNA expression can be seen in the CNS, but expression
is absent in the endodomains.
transheterozygous adults from two unrelated lines recovered from the screen. Within
the region we sequenced there are six introns ranging in size from 56 to 68 base pairs
(Fig. 2). There is a polymorphism in our strains, changing the histidine at position
275 to a leucine. This histidine residue is conserved between humans, mice, and
Xenopus and is present in the DCB2 box (Dynlacht, et al. 1994; Hao, et al. 1995).
However, it is not essential given that strains containing a leucine at this position
have a wild-type phenotype .
We found that both of the mutations were associated with codon changes
within the dDP open reading frame (Fig. 2). The first mutation is a C to T nucleotide
transition that changes Arg149 to a Cys. This residue lies within the DEF box in a
block of amino acids that is highly conserved between DP and E2F, and Arg149 is
conserved between Drosophila, mice, and humans (Dynlacht, et al. 1994; Hao, et al.
1995). With sequence confirmation that the mutation disrupted the dDP ORF, this
allele was named dDPal. The second mutation is a G to A nucleotide transition that
converts Trp1 73 to a stop codon. The resulting truncated protein would lack part of
the DEF box as well as the three highly conserved domains, DCB1, DCB2, and NCB.
This allele was named dDPa2. The molecular data combined with the genetic
complementation data on the five mutations confirm that this complementation
group is the Drosophila dDP gene. Consequently, the other mutations have been
designated dDPa3 , dDPa4 , and dDPa5 .
The role of dDP and dE2F in G1-S progression
In mammalian cells, the E2F transcription factor triggers the expression of
essential S phase genes, and the transcription of these genes correlates with
progression into S phase. In Drosophila, mutations in the dE2F gene were reported to
block the G1-S transition and eliminate detectable DNA replication late in
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Figure 2. Amino acid changes in the dDPa l and dDPa2 mutant lines.
The wild-type Drosophila dDP sequence from a 1400 base pair region PCR amplified
from genomic DNA is compared with the human DP-1 sequence. The amino acid
numbering is that of Dynlacht et al. (Dynlacht, et al. 1994). Amino acid changes in
dDPal and dDPa 2 are indicated, and both of these changes occur in the DEF box
(outlined). The region of genomic DNA sequenced contains six small introns: the
first, in amino acid 28, is 57 bp; the second, in amino acid 71, is 63 bp; the third, after
amino acid 182, is 68 bp; the fourth, in amino acid 261, is 60 bp; the fifth, in amino
acid 289, is 63 bp; and the sixth, in amino acid 317, is 56 bp. The sequence shown
does not include the first 14 amino acids of the N terminus reported by Dynlacht et al.
(1994). The polymorphism is present between our sequence and that of Dynlacht et
al., is shown in bold.
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embryogenesis (Duronio, et al. 1995). We tested whether the mutations in dDP also
would block entry into S phase.
To determine if dDP is required for G1-S progression, we analyzed BrdU
incorporation after the first G1 phase in Drosophila embryogenesis. Normally this
G1 phase is followed by polytene replication in an invariant tissue-specific pattern in
the embryo (Fig. 3A) (Smith and Orr-Weaver 1991). 8 - 15 hour embryos were
collected from dDP mutant lines and labeled with BrdU during a 40 minute interval.
To our surprise we detected BrdU incorporation in embryos homozygous for mutant
alleles of dDP, and the spatio-temporal pattern of BrdU incorporation in these
embryos was normal (Fig. 3B).
The normal replication observed in the dDP mutants prompted us to examine
DNA synthesis in the dE2F9 1 null allele as well as the dE2F71 72 mutant. The
dE2F91 mutation is a stop codon early in the dE2F coding sequence (Duronio, et al.
1995). The dE2F7 172 mutation is also likely to be a null because dE2F protein is not
detectable in homozygous embryos (Asano, et al. 1996). Furthermore, the failure to
observe protein in these mutant embryos implies that maternal pools of the E2F
protein do not persist in late embryos. Strikingly, DNA replication was observed in
embryos mutant for either of the dE2F alleles (Fig. 3C, D), although the intensity of
BrdU incorporation was slightly diminished. As a control, we repeated the 40 minute
BrdU pulse on embryos homozygous for cyclin EPZ5 . As expected, BrdU
incorporation was not detectable in the polytene tissues of cyclin E mutant embryos
(Fig. 3H, arrows). We conclude that even though the bursts of E2F-dependent G1-S
transcription are not evident in dDP and dE2F mutant embryos, DNA replication still
occurs.
Although DNA replication takes place in dDP and dE2F mutant embryos, two
observations suggest that the rate of replication is slowed. First, if a 10 minute pulse
of BrdU labeling was used, BrdU incorporation was reduced in both polytene and
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dE2FI+ dDP dE2F
Figure 3. S phase occurs in dDP and dE2F mutants.
DNA replication was assayed by BrdU labeling of 10.5 hour embryos for either 40 minutes (A-C, H), 20 minutes (D),
or 10 minutes (E-G) followed by antibody staining detected by the HRP reaction. The darkly staining cells are those
that incorporated BrdU during the pulse. The central nervous system (CNS), anterior midgut (amg), central midgut
(cmg), posterior midgut (pmg), malpighian tubules (mt), and hindgut (hg) incorporate BrdU.
The characteristic replication pattern can be seen for the 40 minute BrdU pulse for (A) dE2F7 1 72 /+ embryos which
have a wild-type phenotype, homozygous mutant (B) dDPa4 and (C) dE2F91 embryos, (D) for the 20 minute pulse in
the homozygous dE2F7 1 72 , and (E) for the 10 min BrdU pulse for dE2F7 1 72 /+ embryos. The 10 minute BrdU pulse
for the dDPa4 and dE2F9 1 mutants shows reduced labeling in both the mitotic (CNS) and polytene cells (F, G), but
replication is still detected. (H) There is no detectable replication in the endodomains (arrows) of a cyclin EPZ5
homozygous mutant after a 40 minute BrdU pulse.
neural tissues of homozygous dE2F or dDP embryos (Fig. 3F, G), while replication
was normal with this short pulse in heterozygous controls (Fig. 3E). The previous
studies that concluded DNA replication was undetectable in dE2F mutant embryos
used a short pulse of BrdU labeling (Duronio et al. 1995). However, even with a 10
minute BrdU pulse the level of labeling in dE2F and dDP mutants is much higher
than that obtained in the endodomains with a 40 minute pulse of the cyclin E mutant
(Fig. 3F, G, H). Second, in the dE2F mutants the developmental time of the onset of
the later polytene S phases appeared delayed. Replication persisted in the anterior
and posterior midgut at a developmental stage when only the central portion of the
midgut normally replicates. In the mutant embryos the second round of polytene
replication in the central midgut was not observed (data not shown), suggesting it was
delayed until after cuticle deposition when antibody detection is no longer possible.
Developmental phenotypes of dE2F and dDP
To evaluate whether the E2F/DP transcription factor functions to promote
entry into S phase and/or suppress hyperproliferation, we determined the furthest
developmental point reached by analyzing the lethal phase of both the dE2F and the
dDP mutants. Since S phase occurs during embryogenesis in dDP and dE2F
mutants, we did not expect the mutations to cause embryonic lethality, although the
dE2F mutations were previously described as being embryonic lethal (Duronio, et al.
1995). We tested whether the dDP and dE2F mutants were embryonic lethal by
scoring whether the embryos hatched as first instar larvae. For all five of the dDP
alleles heterozygous mutant/+ females were crossed to Df/+ males. At least 300
eggs were collected and scored, but no embryonic lethality of the dDP alleles in trans
to the deficiency was observed. In the same way, we tested the dE2F9 1 and
dE2F 71 72 alleles in trans to a deficiency that uncovers dE2F. The alleles were also
examined in trans to each other. In each experiment 500 eggs were collected and
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scored, and there was no embryonic lethality. We tested dE2F9 1 homozygous
embryos and found the homozygous chromosome to cause embryonic lethality.
However, this is clearly the result of other mutations on the chromosome, since both
the dE2F91 and dE2F7 172 in trans to a deficiency or each other are not embryonic
lethal.
We examined the role of dE2F in larval and pupal development in order to
determine whether the gene was essential and whether the dE2F mutations caused
any defects in polytenization or cell proliferation. In Drosophila most of the larval
cells do not undergo mitosis after completion of embryogenesis but grow from
polytene replication. However, the imaginal cells that will form the adult body
remain diploid. Thus defects in the endo cell cycle producing polytene cells would
result in small larvae, while defects in proliferation would be manifest after pupation
when the imaginal cells differentiate to produce the adult body. Larvae and pupae
mutant for dE2F were identified by the absence of a dominant marker (see Methods).
Approximately 240 total larvae were examined, and 63% of the dE2F9 1 /dE2F 71 72
survived to third instar. 54% of these third instar larvae initiated pupation. Because
the mutant animals die as late larvae or early pupae, dE2F is clearly essential for
development. The late lethality of the dE2F mutant is consistent with the high levels
of dE2F protein observed in wild-type second and third instar larval extracts (Brook,
et al. 1996).
Although the dE2F mutant animals survive through larval life, we observed a
dramatic delay in larval growth. It took between 288-432 hours for the dE2F mutant
larvae to pupate, compared to 120 hours for heterozygous sibling controls. Five days
after egg laying the dE2F mutant larvae were very sluggish and much smaller in size
than their wild-type counterparts (Fig. 4A, B). The polytene salivary gland and diploid
imaginal discs could not be identified in the five day old dE2F mutant larvae,
presumably because they were so small. The brains were also greatly reduced in size
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as compared to wild-type (Fig. 4 E, F). The size of the dE2F mutant larvae increases
over time (Fig. 4B, C), and the internal tissues approached wild-type size (Fig. 4F, G
and data not shown). DNA replication therefore can occur during this larval period,
but it is slow. Replication in the absence of dE2F is further evidenced by the
formation of banded polytene salivary gland chromosomes in some of the 12-18 day
larvae (Fig. 4H). Although the polytene chromosomes from the dE2F mutant larvae
were smaller and more fragile than normal they were clearly visible. Thus, we
conclude that S phase occurs in the absence of dE2F, but dE2F is necessary for
timely replication and growth.
In addition to the growth delay, the dE2F mutant larvae had another striking
phenotype, melanotic pseudotumors were formed (Fig. 4C, D). Melanotic tumors are
groups of cells within the larvae that are recognized by the immune system and
encapsulated in melanized cuticle (Sparrow 1978; Watson, et al. 1991). We refer to
them as pseudotumors to emphasize that they are not necessarily the consequence
of hyperproliferation but can be abnormal cells recognized by the immune cells.
Small pseudotumors were first observed in the dE2F mutants seven days after egg
laying, and these early pseudotumors grew and darkened as the larvae aged. In the
dE2F mutants that initiated pupation, numerous additional small pseudotumors
formed.
We compared the lethal phenotype of the dDP alleles over a deficiency to that
of the dE2F mutations (Table 1). Unlike the dE2F mutants, the larval growth of the
dDP mutants was not dramatically delayed. The lethality was largely pupal, and
some melanotic pseudotumors were observed in the early pupae. The dDP alleles
ranged in the severity of the phenotype they produced (Table 1). The strongest
phenotype was observed with dDPa5which resulted in late larval lethality when in
trans to a deficiency. The dDPa2 and dDPa4 mutants in trans to a deficiency
survived to the pupal stage. We think that the pupal stage is the lethal phase, and
Figure 4. dE2F is required for wild-type growth in mitotic and polytene tissues.
(A-C) All the larvae are at the same magnification.
(A) dE2F7 172 /+ larva at 5 days AEL (after egg laying).
(B) dE2F91/dE2F7 172 mutant larvae 5 days AEL.
(C) dE2F91/dE2F7172 mutant larva 13 days AEL with two posterior melanotic
pseudotumors.
(D) a magnification of posterior pseudotumors (arrows) shown in C.
(E-G) All the brains are at the same magnification.
(E) brain of dE2F7172 /+ larva at 5 days AEL.
(F) brain of dE2F9 1/dE2F7172 mutant larva at 5 days AEL.
(G) brain of dE2F9 1/dE2F7172 mutant larva at 9 days AEL.
(H) Polytene chromosomes from the salivary glands of dE2F91/dE2F7 172 mutant
larva at 13 days AEL.
Table 1. Developmental phenotypes of dDP mutants
Genotype Lethal Phasea Phenotype
dDpa1/Df(2R)vg-B
dDPa3/Df(2R)vg-B
dDPa2/Df(2R)vg-B
dDPa4/Df(2R)vg-B
dDPa5Df(2R)vg-B
adult flies 11%-20%; adults in
pupal case 80%-89%
adults in pupal case
adults in pupal case 50%;
pupae 50%
rough eyes, incomplete wing vein, thin and
short bristles, etched tergites, more female
files than males, females and males sterile,
females lay eggs with thin chorions
rough eyes, etched tergites, thin and short
bristles
kidney-shaped rough eyes, thin and short bristles
on thorax and head, severe abdominal defects
late larval lethal
aLethal phase is the furthest development stage reached by the dDP mutants.
that the dDPa 5 mutant is unusual. The dDPa 5 larval lethality is either due to
another mutation on the chromosome that enhances the phenotype, or because this
allele is antimorphic. The phenotype of the other alleles in trans to dDPa5 was
stronger than in trans to the deficiency.
Approximately half of the dDpa2/Df pupae reached adulthood in the pupal case
(Table 1). These adults struggled to eclose but ultimately died. Organisms dissected
from the pupal case had essentially normal heads and thoraxes. However, their
abdominal defects were severe. This is informative since the head and thorax are
derived from imaginal discs, while the abdomen arises from the abdominal histoblast
nests. The imaginal discs proliferate during larval stages, but the abdominal
histoblast nests proliferate during pupal development. Thus, pupal lethality may
result from a defect in abdomen formation that occurs during pupal development.
The weakest allele, dDPal, was semilethal in trans to a deficiency (Table 1).
The recovered adults had rough eyes and wing-vein defects. These phenotypes are
diagnostic of compromised mitotic proliferation. They also had thin and short bristles
that indicate a defect in polytene replication, because the cells that give rise to the
bristle shaft and socket endoreplicate (Lees and Waddington 1942). We conclude
that dDP, like dE2F, provides an essential function for the development of the
organism. The eye and bristle defects indicate that dDP is required for normal
development in both mitotic and endo cycle cells.
Genetic interaction between dDP and dE2F
To demonstrate that the late lethality and developmental phenotypes
associated with the dDP mutants were due to loss of dDP function rather than a
synthetic effect with other loci, we tested whether the lethality could be rescued by
expressing the wild-type dDP gene under a heat shock promoter. We introduced an
hsp70-dDP transgene into the dDPal background (Table 2) (Duronio, et al. 1996). At
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25°C we observed a partial rescue of the dDPal /Df lethality due to basal expression
of dDP from the hsp70 promoter. The recovered dDPal / Df; hs-dDP/+ males were
fertile. The recovered adults, however, did have rough eyes, wing vein, and bristle
defects and were female sterile. The effect of induced dDP expression (37 0 C heat
treatment) on the dDP mutants was even more dramatic (Table 2). The lethality of
dDPal /Df was completely rescued, and all the developmental phenotypes were
suppressed. The rescue confirms that the pupal lethality, male and female sterility,
rough eye, wing vein, and bristle defects are all due to loss of dDP function.
Because ectopic expression of dE2F and dDP in the Drosophila eye results in
excess cell proliferation (Asano, et al. 1996; Du, et al. 1996b), we examined the effect
of dDP mutations on eye development in more detail. We used scanning electron
microscopy (SEM) to analyze the eyes of dDPal /dDPa2 ; hs-dDP/+ with and without
heat shock. The eyes of dDP mutant flies carrying the uninduced hs-dDP transgene
were extremely rough (Fig. 5B). The reduced size of the eye, missing and disorganized
ommatidia, as well as stunted, missing and disorganized bristles suggested a
proliferation defect in the dDP mutant (Fig. 5B). Strikingly, flies of the same
genotype that underwent daily heat shock treatments had normal eyes (Fig. 5A, C).
dDPal in trans to a deficiency resulted in the same rough eye phenotype as observed
for dDPal/dDPa2 flies at 25°C, and the rough eye was rescued by induced ectopic
dDP expression (data not shown). Because the dDPa 2 allele exhibits the same
strength phenotype as a deficiency, it genetically behaves as a null allele.
Having shown that heat shock dDP rescues the dDP mutants we defined the
developmental period during which ectopic dDP expression is capable of rescuing the
lethality of the dDP mutants. Females heterozygous for dDPa2 were mated to
heterozygous dDPal males carrying the hs-dDP transgene. The heat shock regimen
began immediately after the 24 hour egg collection was completed or 5 - 6 days later
(late larval / early pupal life). Both treatments yielded the same results, 100% rescue
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Table 2. Rescue of dDP mutants by overexpression of dDP and dE2F
Recovered/expected
Genotype of recovered adults 250C 370C
dDP" /Df; +/+ 1 1%a %d
(males and females sterile)
dDFPa/Df, hs-dDP/+ 42%b  100%e
(males fertile; females sterile) (males fertile; females semifertile)
dDPa'/Df; hs-dE2F/+ 37% 18%'(males and females sterile) (males and females sterile)
w; Df(2R)vg56/CyO females were mated to w; dDPa'/CyO; P[w+;hs-dDP]/+ or w; dDPal/CyO; P[w';hs-dE2F]/+
males at 250C. Eggs collected from the crosses were either allowed to develop at 250C or received heat shock
treatments at 370C.
The recovered adults of the indicated genotype were expected to be one-quarter of the CyO progeny according
to Mendelian ratios (see Materials and Methods): a 9/324, b 34/324, c20/218, d0 /184, e51/184 , '12/266. The
numerator is the number of recovered adults of the indicated genotype. The denominator is the number of the
CyO progeny. To calculate the percentage, the ratios were multiplied by 4.
Figure 5. Overexpression of dDP rescues the eye phenotype of dDP mutants.
Shown are SEMs of Drosophila compound eyes at 200 X magnification.
The genotypes are:
(A) Df(2R)vg-56/ +.
(B) dDPa2 /dDPal with a hsdDP transgene raised at 25°C. The reduced size of the eye and aberrant
morphology are indicative of a proliferation defect in the dDP mutant.
(C) dDPa2/dDPal with a hsdDP transgene raised at 25°C with daily heat shocks at 37 0C. Overexpression
of dDP completely rescues the size and morphology of the dDP mutant eye.
of dDPal/ dDPa2 mutant animals. Thus, the late lethality of dDP mutants is not a
manifestation of a defect in the early development of the organism, but rather it
stems from defects in larval / pupal life.
We tested whether the lethality of dDP mutants was a result of disrupting the
E2F/DP heterodimer by asking whether overexpression of dE2F could suppress the
dDP mutant phenotype. The dE2F transgene under the inducible heat shock
promoter was crossed into the dDPal and dDPa2 background. The dDPal allele was
chosen because this mutation changes a single conserved residue in the E2F/DP
heterdimerization domain (Girling, et al. 1993; Hao, et al. 1995). The dDPa2
mutation truncates the protein and is predicted to delete regions necessary for E2F
binding, providing a useful comparison for the dDPa l mutation. Mild overexpression
of dE2F at 25°C resulted in significant rescue of the dDPal /Df mutant phenotype
(Table 2). At 37 0C the rescue conferred by the ectopic expression of dE2F is
dampened (Table 2). This may result either from high levels of ectopic dE2F
expression being detrimental (Asano, et al. 1996), or it may be due to fewer
dDPal /Df adult escapers arising at 370C. In contrast to the effect on dDPal,
overexpression of dE2F provided no rescue of the dDPa2 mutants (data not shown).
The ability of ectopic dE2F to rescue phenotypes in the dDPal but not the dDPa2
mutants suggests that despite the alteration in the DEF box of the dDPal allele, the
mutant DP protein is still capable of binding E2F. This observation also indicates
that the dDP phenotypes are a result of a failed E2F/DP transcription factor activity.
Genetic interactions between the E2FIDP heterodimer and cyclin E
We investigated whether dDP is necessary for cyclin E expression. In embryos
that were dDPal / Df cyclin E expression was not detectable in the endodomains but
present in the CNS (Fig. 6A, B), a pattern comparable to that seen in homozygous
dE2F91 mutant embryos (Fig. 6C). Because the levels of cyclin E transcripts are so
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Figure 6. cyclin E expression in dDP and dE2F mutant embryos.
Cyclin E transcripts were detected by whole-mount in situ hybridization.
(A) In wild-type 10.5 hour embryos cyclin E is expressed at high levels in the
mitotically proliferating CNS and at low levels in the endodomains. (The
endodomains are labeled as in Fig. 1).
(B) In dDPal/Df 10.5 hour mutant embryos cyclin E is expressed at high levels
in the CNS but is undetectable in the endodomains.
(C) dE2F9 1 homozygous mutant 10.5 hour embryos show the same phenotype.
cyclin E is expressed at high levels in the CNS but is undetectable in the
endodomains.
much higher in the nervous system than in the endodomains, it is difficult to assess
whether the transcript levels are reduced in the mutants in the CNS.
The cyclin E mutant phenotype is more severe than that of the dE2F and dDP
mutants, even though cyclin E transcription requires the E2F/DP transcription
factor. In contrast to the near normal pattern of replication seen in dE2F and dDP
mutant embryos, DNA replication was not detected in the endodomains of embryos
homozygous for cyclin EPZ5 (Fig. 1H). In this cyclin E allele S phase continued in the
CNS in late embryos (Fig. 1H). No embryonic lethality resulted from the cross of
cyclin EPZ5 heterozygous mothers to fathers heterozygous for a cyclin E deficiency,
rather the cyclin EPZ5Df transheterozygotes died as early first instar larvae. Since
BrdU incorporation is not seen in cyclin E mutant embryos in the endodomains, this
shows that the embryonic endocycles are not required for hatching.
We tested whether persistent maternal levels or low levels of zygotic
expression of cyclin E transcript accounted for the viability of dE2F mutant larvae.
In contrast to the pupal lethality normally seen with dE2F9 1 / dE2F7172 , reducing the
maternal dosage of cyclin E dramatically enhanced the lethality. This resulted in
early larval lethality, with only 5% of the dE2F mutant larvae surviving until the
second to small third instar larval stage. Reducing the dosage of the cyclin E gene in
the father also enhanced the dE2F lethality, but to a lesser extent. In this cross 30%
of the cyclin EPZ5/+;dE2F91/dE2F7172 progeny survived until the second to third
instar larval stage. The pronounced effect of reducing the gene dosage in mother
indicates that persistent maternal pools of cyclin E transcript or protein permit
viability of dE2F mutant animals. In addition, zygotically provided transcripts also
contribute, but we cannot distinguish whether this is due to persistence of
constitutively expressed transcripts or cyclic transcription below our detection limit.
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Discussion
From a genetic screen to identify mutants that fail to undergo the S phase
transcriptional program during embryogenesis we recovered five mutations in the
Drosophila DP gene. The mutant phenotype reveals that dDP, like dE2F, is required
for viability in Drosophila and that the gene has an essential role in vivo. The
mutant phenotypes of dDP and dE2F provide insight into the functions these genes
provide in controlling the cell cycle during development.
The E2F/DP transcription factor promotes S phase in vivo
Analysis of the activity of E2F in mammalian cell culture showed that the
transcription factor was capable of driving cells into S phase when overexpressed and
that this could lead to apoptosis (Heibert, et al. 1995; Johnson, et al. 1993; Lukas, et
al. 1996; Shan and Lee 1994). This observation was consistent with results
demonstrating that E2F could activate the transcription of a number of genes needed
for the G1-S transition and the onset of S phase. However, it was also shown that
when complexed with pRB the E2F transcription factor could repress the
transcription of some of these genes in G1 (Weintraub, et al. 1995; Weintraub, et al.
1992; Zwicker, et al. 1996). In transgenic mice in which the E2F-1 gene was disrupted
tumors developed (Field, et al. 1996; Yamasaki, et al. 1996). These latter two
observations raised the possibility that in some tissues the E2F transcription factor
could act primarily as a tumor suppressor to repress progression of the cell cycle.
The phenotypes of the Drosophila E2F and DP mutants reveal that the E2F
transcription factor indeed plays a significant role as an activator of S phase in vivo.
It was surprising that mutations in either gene have almost no effect on BrdU
incorporation during embryogenesis. However, the rate of nucleotide incorporation
and DNA replication appears to be slower in both mutants, and the slow larval
growth rate in dE2F mutants is particularly striking. Because larval growth occurs
by increasing ploidy of the larval tissues via the G-S endo cycle, these phenotypes
reflect a compromised ability to undergo S phase in the mutants.
In addition to the effects on polytene tissues, mitotically proliferating cells are
dramatically affected by mutations in both dE2F and dDP. In the dE2F mutants
that pupariate, either a very small adult body is formed inside the pupal case or an
adult body is not formed at all. This is consistent with a defect in proliferation that
reduces the number of imaginal disc cells and abdominal histoblasts that give rise to
adult structures. It was previously observed that mutations in dE2F reduce the rate
of cell growth in clones in the eye (Brook, et al. 1996). The interpretation that
mutations in the dE2F and dDP genes disrupt the diploid cell cycle in the imaginal
cells is supported by experiments demonstrating that overexpressing dE2F and dDP
induced S phase and excess cell proliferation in the eye (Asano, et al. 1996; Du, et al.
1996b).
The defects in diploid larval cells most likely arise from aberrant cell
proliferation caused by the dE2F and dDP mutations. Although we do not know the
cell cycle stage affected, the demonstrated effects on polytene larval cells imply that
it is the G1-S transition. Because the imaginal discs are present in dE2F mutants
yet fail to differentiate to produce adult tissues, it is also likely that E2F has a role in
post-mitotic differentiation. Such a role was previously demonstrated by clonal
analysis in the eye disc (Brook, et al. 1996). A failure in differentiation of the imaginal
cells could be a contributing factor in the dDP mutant phenotypes as well.
Although the mutant phenotypes suggest that the predominant function of the
E2F transcription factor in Drosophila is to promote progression of the cell cycle, two
observations raise the possibility that it may have an inhibitory role in some tissues.
First, in dDP mutant embryos a low level of RNR2 transcripts are present in the
epidermis, and these may result from a failure to repress transcription. Second,
melanotic pseudotumors develop in the dE2F and dDP mutants. We refer to these as
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pseudotumors because they arise in Drosophila larvae when the lamellocytes of the
immune system recognize aberrant cells, surround them, and secrete a cuticle that
melanizes and becomes black (Sparrow 1978). Thus the clearest cause of melanotic
tumors is an alteration of the cell surface. In the dE2F and dDP mutants this could
result from perturbation of the differentiation program or apoptosis. There is
evidence in Drosophila suggesting that overproliferation may contribute to melanotic
tumor formation (Bryant, et al. 1993; Watson, et al. 1991; Watson, et al. 1994;
Watson, et al. 1992). Although it is possible that the melanotic pseudotumors in the
dE2F and dDP mutants result from hyperproliferation, we did not observe
overproliferation in the larval imaginal tissues. Apoptosis may occur in some tissues
in the dE2F and dDP mutants, leading to melanotic tumors. Further analysis will be
required to determine whether E2F represses the cell cycle in some developmental
contexts and to distinguish between these potential mechanisms for the formation of
melanotic pseudotumors in the mutants.
Does dE2F have a function that is independent of dDP?
While both the dDP and dE2F mutants show late lethality, there are
differences in the phenotypes resulting from mutations in the two genes. The dE2F
mutant animals have slower larval growth than dDP mutants, and the dDP mutants
develop farther as pupae. We think that the difference in strength of the phenotypes
reflects the biological system rather than strength of the dE2F and dDP alleles,
because we analyzed null alleles of both genes. The dE2F91 mutation is a truncation
after amino acid 31 (Duronio, et al. 1995), and dDPa2 is a truncation at the end of the
DEF box. In mammalian cells truncation of DP after the DEF box abolishes both the
E2F and DNA binding ability (Wu, et al. 1996). Given the high degree of conservation
between the mammalian and Drosophila proteins, dDPa2 is likely to ablate DP
activity.
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One explanation for the less severe phenotype of the dDP mutations is that
there is a redundant activity for dDP but not for dE2F. This could be because there
are additional family members in the Drosophila genome, and these may complement
the dDP defect better than that of the dE2F mutants. Alternatively, the maternal
stockpiles of the dDP gene may persist longer than those of dE2F. The levels of DP
protein are higher than those of E2F in the embryo (N. Dyson, personal
communication).
Another explanation for the more severe effects exhibited by the dE2F
mutants is that dE2F plays biological roles independent of dDP. Possibly the dE2F
protein can act as a transcription factor as a homodimer. The rate of larval growth is
influenced greatly by nutritional signals (Poodry and Woods 1990). One possibility is
that dE2F links the endo and mitotic cell cycles to nutritional input, and it does so
without requiring dDP function.
Significance of E2F/DP-dependent GI-S transcription
There is a clear correlation between the E2F/DP-dependent transcriptional
activation of genes whose products are necessary for DNA replication and the onset
of S phase. The implication was that this relationship was causal and that the cyclic
transcription of these genes, some of which like cyclin E are known to be key
regulatory genes, was necessary for normal S phase. The striking observation from
the Drosophila dDP and dE2F mutants is that although cyclic transcription of cyclin
E, PCNA, and RNR2 is not detectable, S phase still occurs. Although we cannot
exclude the possibility that cyclic transcription of these genes occurs at a low level
driven by maternal pools of dDP and dE2F, the bursts of transcription that normally
preceed S phase are not essential for the G1-S transition. In these mutants the cell
cycle may be driven by basal levels of transcripts and post-transcriptional regulation.
The maternal pools of components of the replication machinery can persist until late
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in development, as evidenced by the fact that mutations in PCNA and MCM2 cause
late larval lethality (Henderson, et al. 1994; Treisman, et al. 1995).
The precise developmental control exercised over the cell cycle in Drosophila
permits the in vivo role of cell cycle regulators to be evaluated. The ability to
visualize the G1-S transcriptional program during embryogenesis enabled us to
recover mutations in dDP. While the mutant phenotypes reveal that dE2F and dDP
promote progression of the cell cycle, they reveal a distinction between the effect on
E2F/DP-dependent G1-S transcription and the onset of S phase.
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Materials and methods
Fly strains
The cn bw sp and DTS 91 strains were provided by R. Lehmann. The Ubx
-lacZ CyO balancer chromosome has been described previously (McCall, et al. 1994).
The cyclin EPz5 allele and the cyclin E deficiencies Df(2L)TE116(R)GW1 and
Df(2L)TE116(R)GW3 were acquired from J. Roote.
The dE2F91 and dE2F7172 alleles have been described previously (Duronio, et
al. 1995). The P[w+, hsp70-dE2F]and P[w+, hsp70-dDP] strains were provided by N.
Dyson (Duronio, et al. 1996). The deficiencies uncovering the dDP gene, Df(2R)vg-33,
Df(2R)vg-56, and Df(2R)vg-B, have been described previously (Lasko and Pardue
1988; Morgan, et al. 1938; Williams and Bell 1988)and were provided by R. Duronio
and the Bloomington stock center. The deficiency uncovering dE2F, Df(3R)e-BS2
was obtained from the Bloomington stock center.
Genetic screen
Isogenized cn bw sp homozygous males were fed 35 mM EMS in a 1% sucrose
solution for a 24 hour period (Fig. 7). Immediately after feeding, these males were
crossed to virgin females heterozygous for a chromosome carrying a dominant
temperature-sensitive mutation, DTS91 pr cn and a CyO balancer carrying a lac Z
reporter gene under the control of the Ubx promoter, (Ubx-lacZ CyO). Single male
progeny from this cross with the genotypes cn bw sp/P[Ubx-lacZ] CyO and cn bw
sp/DTS91 pr cn were collected and mated individually to DTS91/P[Ubx-lacZ] CyO
virgin females. To facilitate collection of the desired cn bw sp /P[Ubx-lacZ] CyO virgin
females and male progeny, the vials were placed at the restrictive temperature for
the DTS91 mutation, 290C, for three days. The adults were removed, and the vials
were incubated at 290C for an additional day before being moved to 250C. cn bw
sp/P[Ubx-lacZ] CyO virgin female and male progeny from this cross were collected
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Figure 7. Screen for mutations that disrupt Gl-S transcription.
Isogenized cn bw sp flies were mutagenized with EMS. The DTS91 chromosome was
used to select for flies bearing the mutagenized chromosome over a balancer
expressing lacZ. From the F3 adults, 8-15 hour embryos were collected and
hybridized in situ with PCNA and lacZ riboprobes. Embryos that did not express lacZ
were homozygous for the mutagenized second chromosome. F3 lines that gave rise to
progeny with aberrant PCNA expression were maintained.
DTS91 pr cn
P[Ubx-lacZ]CyO
DTS91 pr cn
P[Ubx-lacZ]CyO
(cn bw sp) *
P[Ubx-lacZ]CyO
single d'
(cn bw sp)*
DTS91 pr cn
29' 4 days
250
(cn bw sp)* 0
P[Ubx-lacZ]CyO
(cn bw sp)* 99
P[Ubx-lacZ]CyO
Collect embryos and examine by in situ hybridization.
EMS
cn bw sp
cn bw sp
dcd
Fl:
F2:
F3:
and mated to establish mutant lines. 8-15 hour embryos were collected from these
lines and hybridized in situ with a PCNA riboprobe. To distinguish between embryos
homozygous for the cn bw sp mutagenized chromosome and their heterozygous cn bw
sp/Ubx-lacZ siblings, the embryos were simultaneously hybridized with a lacZ
riboprobe.
In situ hybridization
In situ hybridization was carried out essentially as described previously, (Tautz
and Pfeifle 1989). To perform in situ hybridization on large numbers of independent
samples multiwell baskets were used. Hybridization was carried out at 650C.
Digoxygenin labelled antisense RNA probes were made as described in the Boehringer
Mannheim kit. The RNR2 clone used to make probe was obtained by PCR
amplification of Oregon R genomic DNA using degenerate primers (Duronio and
O'Farrell 1994). The PCR products were cloned into Bluescript KS. Cyclin E probes
were made from the E41-1 clone obtained from H. Richardson (Richardson, et al.
1993). The PCNA probe was made from a full length cDNA isolated in this
laboratory by J. M. Axton from the library generated by N. Brown (Brown and
Kafatos 1988). lacZ probes were made from the pC43gal plasmid (Thummel, et al.
1988).
Sequence analysis of the dDP alleles
Transheterozygous dDP/Df(2R)vg-B third instar larvae were collected from a
cross of dDP/T(2;3)TSTL14 and Df(2R)vg-B/T(2;3)TSTL 14 adults by selecting non-Tb
larvae. T(2;3)TSTL14 is a translocation between the balancers SM5 and TM6B that
carries the dominant larval / pupal marker Tubby (Tb) (Gatti and Goldberg 1991). To
recognize polymorphisms between our strains and the published sequence, we
isolated DNA from adults that were transheterozygous for two unrelated lines
created in our screen. Genomic DNA was isolated from these larvae and adults and a
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1400 base pair region encompassing approximately amino acid 15 to 377 (Dynlacht,
et al. 1994) was amplified by the polymerase chain reaction. Because two different
5' ends have been described for the dDP gene (Dynlacht, et al. 1994; Hao, et al. 1995),
the amplified region contained the conserved domains but not the 5' end of the gene.
The amino acid numbering is that of Dynlacht et al. (1994). Primer sequences were '5
CTTTAGTCAGATGGGCAGTCAAG3' and 5'CTGTAACTAACTCGACTACCAC3'.
10-15 separate PCR reactions were pooled and sequenced directly in the Whitehead
sequencing facility using fluorescence automated sequencing. Primers for sequencing
were spaced at approximately 300 base pair intervals.
BrdU labeling
8 - 15 hour embryos were labeled with BrdU according to a protocol obtained
from Rolf Bodmer, a modified version of Bodmer, et al. (1989). After permeabilization,
the embryos were incubated with BrdU for either 10 or 40 minutes at room
temperature. The fixed embryos were hydrolyzed in 2N HCI for 70 minutes. The 70
minute acid treatment is the key difference from the published protocol and provides
better detection of the label. The balancers used to maintain the dDP and dE2F
mutant lines were marked with a Ubx-lacZ transgene. An anti--galactosidase
antibody (Promega) was used in conjunction with the anti-BrdU antibody to
distinguish the 25% homozygous mutant embryos from their siblings. The antibody
staining was detected using the horseradish peroxidase histochemical reaction
(Bodmer, et al. 1989).
Lethal phase
Embryonic lethality was assessed by mating dDP allele / + females to
Df(2R)vg-B / CyO males. The parents were allowed to mate at 25°C for several days
to reduce the number of unfertilized eggs in the collections. The eggs were collected
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on apple juice plates at 25°C and counted. The number of eggs that hatched was
recorded 24 hours later. The same procedure was carried out for alleles of dE2F. The
furthest developmental stage reached by the dDP alleles in trans to each other or in
trans to Df(2R)vg-B was determined by generating stocks with the dDP alleles and
the deficiency over T(2;3)TSTL 14 (Gatti and Goldberg 1991). The dE2F alleles were
balanced over TM6B to determine the lethal phase.
To test for the effect of reducing the dosage of cyclin E on the viability of dE2F
mutants two reciprocal crosses were done. The effect of zygotic expression alone was
examined by crossing dE2F7172 / TM6B females to cycEPZ5; dE2F91 / TSTL males.
The effect of the maternal plus the zygotic contribution was tested by the reciprocal
cross.
Heat shock rescue experiments
w; Df(2R)vg-56/CyO females were mated to w; dDP al /CyO ; P[w+;hs-dDP]/ +
or w; dDPal/CyO ; P[w+;hs-dE2F]/+ males at 25°C (Duronio, et al. 1996). All the
progeny from the cross were counted and placed into genotypic classes. To test for
rescue of dDPal/dDPa2 transheterozygotes, dDPa2/CyO females were crossed to w;
dDPal/CyO; P[w+; hs-dDP]/TM3, Sb males at 250C. No dDPal/dDPa2 adults were
observed.
For the heat shock treatments, embryos were collected (from the crosses
shown above) for 24 hours at 250C in vials. The heat shock treament was
administered by placing the vials in a 370C air incubator for an hour and then the
vials were returned to 25°C. The heat shocks were initiated either immediately after
the completion of a 24 hour collection or after the eggs were allowed to develop at
25 0C for 5-6 days. In either case, subsequent heat shocks were delivered two times
daily.
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Chapter Four
E2F/DP controls the activity of DNA replication origins
Irena Royzman and Terry L. Orr-Weaver
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Abstract
We demonstrate that in Drosophila E2F/DP controls differential regulation of
replication origins within S phase. In the nurse cells of the ovary, E2F/DP limits the
use of replication origins in the heterochromatin. In follicle cells, E2F/DP plays a dual
role in the transition from genomic replication to the amplification of chorion loci; it is
required to shut off genomic replication and to activate amplification. In a dE2F
mutant that lacks the C-terminal transcriptional activation and RB-binding domain
we observed over-amplification. In addition to the positive and negative effects on
replication origins, we show that E2F/DP is required for the transport of nurse cell
contents to the developing oocyte and subsequent nurse cell apoptosis.
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Introduction
A significant body of work suggests that the E2F transcription factor plays a
pivotal role in the control of S phase entry. The transcription factor is a heterodimer
of E2F and DP proteins, and there are several forms of both proteins in mammalian
cells (Weinberg, 1995). E2F-binding sites are found in the promoters of genes that
are required for DNA synthesis and those that regulate S phase entry (Nevins, 1992).
E2F sites can act both as positive and negative elements depending on whether E2F
is free or complexed with a pocket protein such as the retinoblastoma protein (RB)
(Weintraub et al., 1992). The E2F/DP heterodimer tethers RB to E2F-dependent
promoters through a small RB-binding region embedded in the transactivation
domain of the E2F protein (Helin et al., 1993). In addition to occluding the E2F
activation domain, RB actively represses transcription at these promoters and can
affect the state of chromatin condensation through an interaction with a histone
deacetylase (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998;
Weintraub et al., 1995). Late in G1, phosphorylation of RB by cyclin D/CDK4,6 frees
E2F/DP and triggers the expression of E2F-dependent genes including cyclin E (Botz
et al., 1996; Ewen et al., 1993; Geng et al., 1996; Kato et al., 1993; Ohtani et al.,
1995). The cyclin E/CDK2 complex also phosphorylates RB and creates a positive
feedback loop that is thought to result in an irrevocable commitment to S phase
(Sherr, 1996).
It is not clear whether the predominant role of E2F in vivo is negative or
positive. Ectopic expression of the best characterized E2F protein, E2F-1, is
sufficient to drive serum-starved, quiescent fibroblasts through S phase, suggesting a
positive role in S-phase entry. (Johnson et al., 1993; Qin et al., 1994). The E2F-1
induced fibroblasts then become apoptotic. The induction of apoptosis, however, may
be a secondary consequence of driving cells into an ectopic S phase. Recent studies
indicate that the induction of DNA synthesis and apoptosis are separable functions of
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E2F-1. Ectopic expression of a transactivation defective E2F-1 mutant induces cells
to undergo apoptosis but not DNA replication (Hsieh et al., 1997; Phillips et al., 1997).
The importance of the transcriptional activation domain of E2F-1 for the induction of
S phase was established in a previous study (Qin et al., 1995). Furthermore,
overexpression of a dominant-negative DP-1 mutant results in a block to G1-S
progression (Wu et al., 1996). These findings suggest that E2F-1 may be a
transcriptional activator of G1-S progression and a repressor of apoptosis.
Analyses of mice lacking a functional E2F-1 gene have challenged the models
established by the overexpression studies. E2F-1- - mice are viable and fertile but
develop tumors in a variety of tissues (Field et al., 1996; Yamasaki et al., 1996). In
addition, large and sometimes binucleate cells are detected in the exocrine gland, and
in vitro cultured E2F-1-/- thymocytes are less susceptible to apoptosis than their
wild-type counterparts. The predisposition to tumors and exocrine gland dysplasia
suggest a previously unrecognized tumor suppressor function for E2F-1. Moreover,
these studies indicate that E2F-1 is either not critical for entry into S phase or that
other members of the E2F family (E2F-2 through -5) can compensate for this
function. It is not clear whether the overexpression studies or the knockout mice
come closer to reflecting the physiological role of E2F-1. Isolation of a range of
mutations in addition to the null would provide significant insights into the function of
E2F-1 in vivo.
Drosophila homologs to E2F, DP, and an RB-like protein (RBF) have been
identified (Du et al., 1996a; Dynlacht et al., 1994; Hao et al., 1995; Ohtani and
Nevins, 1994). As in mammalian cells, ectopic dE2F expression is sufficient to drive
quiescent cells into S phase and apoptosis (Asano et al., 1996; Du et al., 1996b).We
have shown that null mutations in dE2F and dDP cause lethality late in development
with some tissues being underdeveloped or absent (Royzman et al., 1997). A positive
role for the E2F/DP heterodimer in cell cycle progression was inferred from these
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defects. In addition, G1-S transcription of cyclin E and genes encoding replication
functions (proliferating cell nuclear antigen and ribonucleotide reductase 2), normally
observed in late embryogenesis, is missing in the dE2F and dDP mutants (Duronio et
al., 1998; Duronio et al., 1995; Royzman et al., 1997). Despite the pronounced effect
on E2F-dependent G1-S transcription, a block to replication was not observed.
However, replication did appear slower.
Drosophila oogenesis makes it possible to examine aspects of DNA replication
that are not readily apparent during embryogenesis (for review see Spradling and Orr-
Weaver, 1987; Spradling, 1993). Ovarian nurse cells and follicle cells undergo a set of
mitotic divisions before switching to an endo cycle (a cycle consisting of only S phase
and a gap phase) and becoming polyploid. During polyploidization, the parameters of
S phase are altered such that differential regulation of replication origins throughout
the genome occurs. In both the nurse cells and follicle cells, the heterochromatin is
underreplicated. In the follicle cells a few genomic intervals escape restrictions on re-
replication, and these regions continue to be amplified after the cessation of genomic
replication. Weak alleles of essential cell cycle genes exhibit defects in oogenesis for
two reasons. Polyploidization and amplification place demands on DNA replication
factors. In addition, maternal pools of most cell cycle regulators and components of
the DNA replication machinery are depleted in the adult. Thus, weak alleles of cyclin
E, PCNA, and orc2 are female sterile (Henderson et al., 1994; Landis et al., 1997; Lilly
and Spradling, 1996).
Here we report the identification and analysis of new mutations in Drosophila
dE2F that cause cell cycle defects in oogenesis. These mutations, in addition to a
previously isolated female-sterile allele of dDP (Royzman et al., 1997), allowed us to
define the role of E2F in DNA replication. We demonstrate that in different
developmental contexts E2F/DP is needed to inactivate or activate DNA replication
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origins. In addition, we show that the E2F/DP heterodimer is required for nuclear
lamin breakdown and developmentally-induced apoptosis in vivo.
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Results
Female-sterile mutations in the dE2F gene
We recovered two viable mutations in the gene for the dE2F subunit of the
E2F transcription factor from a screen for mutations affecting G1-S transcription
during embryogenesis. The PCNA gene, a target of E2F, is transcribed in a
stereotypic pattern that anticipates DNA replication late in Drosophila
embryogenesis (Duronio and O'Farrell, 1994). This pattern was used as the basis for
a screen to identify regulators of the G1-S transition, as previously described
(Royzman et al., 1997). From 1000 mutagenized third chromosome lines established
by Moore et al. (1998), we focused on two mutants with reduced PCNA expression
during embryogenesis (data not shown).
We sought to determine if the two mutations were alleles of the dE2F gene.
One mutation when placed in trans to a deficiency or a null dE2F allele caused
reduced viability. The recovered adults were female sterile and had eye and bristle
defects. The mutant females were able to lay eggs, but the eggs failed to develop.
These phenotypes closely resemble those observed for a weak allele of dDP, dDPal
(Royzman et al., 1997). The other mutation was fully viable in trans to a deficiency
or null dE2F allele; these adults had slightly rough eyes and the females had reduced
fertility. Unexpectedly, the two alleles were viable and fertile in trans to each other.
Thus, the complementation data were ambiguous and left open the possibility that
these were either alleles of dE2F or mutations in interacting genes.
To determine if the mutations were in the dE2F gene, we sequenced the dE2F
coding regions from the mutants. Both mutants had changes in the dE2F open
reading frame (Fig. 1). The mutation that is semi-lethal in trans to a deficiency is a G
to A nucleotide transition that converts amino acid Asp 29 6 of the dE2F DNA-binding
domain to Asn. This residue lies in a region that is highly similar between the E2F
and DP families of proteins, and it is conserved in all known Drosophila and
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Figure 1. Position and nature of new dE2F alleles.
(A) A schematic of the dE2F protein with the conserved regions indicated: the DNA-
binding domain, leucine zipper, transcriptional activation domain, and the embedded
RB-binding region in black. The positions and the amino acid changes in dE2Fi l and
dE2Fi 2 are shown relative to dE2F9 1 , the previously characterized null allele
(Duronio et al., 1995; Royzman et al., 1997).
(B) The dE2F DNA-binding domain includes a region of considerable similarity
between the DP and E2F families of proteins. This block of amino acids is called the
DEF box in the DP gene, and it is important for E2F/DP dimerization and the
recognition of E2F/DP binding sites in the promoters of E2F/DP regulated genes
(Bandara et al., 1993; Hao et al., 1995). The DEF consensus for Drosophila DP and
E2F proteins is shown (modified from Bandara et al., 1997). A broader consensus to
include mammalian DPs (1-3) and E2Fs (1-5) as well as the recently identified E2F-
like protein, E2F6/EMA (Morkel et al., 1997; Trimarchi et al., 1998) is indicated in
bold. The positions of mutations dDPal, dE2Fi l and dDPa2 are shown within the
DEF consensus. dDPa l is an amino acid substitution, while dDPa2 is a stop codon.
Note that the affected residues are perfectly conserved in all known Drosophila and
vertebrate E2F and DP families of proteins.
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vertebrate E2F and DP proteins (Fig. 1B) (Bandara et al., 1997; Hao et al., 1995).
The mutation was named dE2 1il. The finding that the dE2 i l mutation is
analogous to the missense change in the DNA-binding region in the dDPa l allele may
explain the similarity of the phenotypes exhibited by the two mutants (see Fig. 1B).
The second mutation, dE2Fi 2 , is a C to T change that converts Gln 52 7 to a stop
codon, resulting in the deletion of the transcriptional activation and RB binding
domains. The C-terminal domain of the Drosophila E2F protein shown to be both
necessary and sufficient for transcriptional activation (Ohtani and Nevins, 1994) is
completely missing in this mutant.
Phenotypic analysis of Drosophila E2F91 , a null allele that lacks all the
recognized functional domains of the E2F family of proteins, established that dE2F is
essential for viability and normal growth (Duronio et al., 1995; Royzman et al., 1997).
However, viability and growth are not affected in the dE2Fi2 mutant. Thus, the
dE2Fi 2 mutant appears to retain significant physiological function. This was also
evidenced by another observation. Cyclin E is a critical target of E2F in Drosophila
(Duronio et al., 1996). We tested whether reducing the dosage of the cyclin E gene by
half would effect the viability of dE2Fi2 / dE2F 91 flies and found that it had no effect.
In contrast, the same reduction enhanced the lethality of the dE2Fi l IdE2F9 1
mutant organisms. We were not able to recover dE2Fil /dE2F91 adults that were
heterozygous for a strong but completely recessive cyclin E mutation.
dE2F and dDP limit replication of heterochromatin
The female sterility of the dDPa l , dE2Fi l , and dE2Fi2 mutants suggested
there were defects in oogenesis. Although the ovaries were small, the cell cycle
appeared normal in the mutants. The mutant egg chambers contained 16 germline
cells, 15 nurse cells and an oocyte, indicating the proper completion of the four mitotic
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divisions that produce the egg chamber cyst. In addition, the nurse and follicle cells
were undergoing polyploidization as evidenced by the size of the nuclei.
Although the nurse cells were polyploid, the properties of endoreplication were
affected in all three mutants. Normally, replication in nurse cells is incomplete, with
sequences residing in heterochromatic regions of the genome being underrepresented
(Fig. 2A,B) (Hammond and Laird, 1985; Lilly and Spradling, 1996). Staining with the
DNA dye DAPI gives one or a few small, intensely labeled, chromocenters, aggregates
of heterochromatic sequences, in each nurse cell nucleus. It has been shown that size
of the chromocenter reflects the levels of heterochromatic sequences, and mutations
that restore late replication to polyploid cells result in a much larger chromocenter
(Lilly and Spradling, 1996). DAPI staining of dE2Fi2 /Df mutant ovaries showed a
dramatic increase in the size of the nurse cell chromocenter (Fig. 2C), whereas
underreplication was normal in the heterozygous controls (Fig. 2A). The same
relative over-replication of heterochromatic regions was observed for dE2Fi l and
dDPa l (data not shown).
The mutant phenotype suggests that E2F/DP influences the use of late
replicating origins. To establish that this effect was due to loss of E2F function and
not a novel E2F activity in these mutants, we rescued the lethality of null
dE2F9 1and dDPa2 mutants by their respective hsp70-dE2F and hsp70-dDP
transgenes. A partial rescue of lethality was achieved with basal expression of the
wild-type genes from the hsp70 promoter. These flies would be expected to have
reduced E2F activity relative to wild-type, however, they retain enough function to be
viable. The recovered hs-dE2FI+; dE2F91 /Df and dDPa2 Df; hs-dDP/+ mutant
adults had rough eyes and were female sterile. DAPI staining revealed that the nurse
cell chromocenters in the mutants were increased in size and intensity as compared
to controls (data not shown). These results establish that the increased presence of
nurse cell heterochromatin is due to loss of E2F function.
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Figure 2. E2F/DP is required in nurse cells to limit the usage of late replicating origins.
DAPI was used to monitor the degree of underrepresentation of heterochromatic
sequences.
(A) In control dE2Fi 2 / + stage 10 nurse cells underreplication was normal and the
chromocenter is scarcely visible (arrow).
(B) Schematic of replication in polyploid cells: sequences residing in heterochromatic
regions (curved lines) of the genome are not completely duplicated.
(C) In mutant dE2Fi 2 IDf stage 10 nurse cells normally underrepresented
heterochromatic sequences are restored to nurse cell nuclei. Note the large and
intensely staining chromocenter in each nurse cell nucleus (arrows). The same
phenotype was observed for the other female-sterile mutants, dDPa l IDf and
dE2Fi l / dE2F9 1 , as well as the nulls that were rescued to adulthood, dDPa2 /Df and
dE2F9 1 /Df (data not shown).
(D) Schematic showing the restoration of heterochromatic sequences in the mutants.

The role of dE2F and dDP in chorion gene amplification
It was of interest to determine if E2F/DP regulates other examples of
differential replication. In follicle cells chorion gene clusters escape restrictions on
rereplication, and amplification of these regions continues after the cessation of
general genomic replication (Calvi et al., 1998). The amplification of chorion genes in
follicle cells is required for the rapid synthesis of the eggshell (chorion), thus mutations
that disrupt this process cause female sterility and thin eggshells. Consistent with a
defect in chorion amplification, eggs laid by dDPa l /Df and dDPa2 /Df ; hsDP/+
mutant mothers, had abnormally thin eggshells (data not shown). The eggshells
produced by the dE2F mutants were also indicative of an amplification defect, but
the phenotype was more variable (data not shown).
To determine the role of E2F/DP in chorion gene amplification directly, we
analyzed BrdU incorporation in whole-mount ovaries (Figs. 3, 4 and Table 1). In wild-
type ovaries the shift from general genomic replication to amplification of chorion
genes is readily observed. During genomic replication, BrdU is incorporated
throughout the entire follicle cell nucleus, and groups of follicle cells in the same egg
chamber undergo BrdU incorporation at different times to give an asynchronous
pattern (Fig. 3A,A'). The cessation of genomic BrdU incorporation is followed by
continuous amplification of chorion genes. During amplification (stages 10B-13),
BrdU is incorporated in all the follicle cells at the same time but only at four
subnuclear foci (Fig. 3B,B',see circle in B'). The subnuclear BrdU dots correspond to
amplifying regions of the genome (Calvi et al., 1998). In the dDP and dE2F mutant
ovaries, replication prior to stage 10B was normal; both labeled (S phase) and
unlabeled (G phase) follicle cell nuclei were observed (data not shown). However, the
mutants deviate from wild type and each other during amplification (stage 10B and
later) (Table 1).
121
Figure 3. dDP is necessary for amplification and the shut off of genomic replication.
(A-D) DNA replication was assayed by BrdU labeling followed by antibody staining
detected by the horseradish peroxidase (HRP) reaction. BrdU incorporation is
indicated by the red staining. A DAPI counterstain to detect all nuclei was also used.
Panels A-D are at the same magnification, and are shown below (A'-D') at a higher
magnification.
(A, A') In stage 9 control dDPal / + egg chambers genomic replication is asynchronous
among follicle cell nuclei. The egg chamber contains follicle cells that are labeled (S
phase) with BrdU and those that are not labeled (G phase). The same pattern of
nuclear BrdU incorporation is observed in the female-sterile dE2F and dDP mutants.
(B, B') In stage 10B control egg chambers, polyploidization of the follicle cell genome
is no longer observed. Instead, synchronous subnuclear BrdU incorporation is seen.
The subnuclear dots correspond to amplifying chorion clusters. The subnuclear foci
from a single follicle cell nucleus are indicated by a circle. The different intensity and
size of foci (one large, one medium, and two small ) reflect the extent of gene
amplification.
(C, C') A stage 10B dDPa2 / Df mutant egg chamber is shown. Genomic replication is
persistent and synchronous in this mutant egg chamber. The same phenotypes were
observed for the dDPal IDf mutant. Note that the nuclei are much larger than at
stage 9. It is the shut off rather than the onset of polyploidization that is defective in
the mutants.
(D) A stage 10B dDPa l / Df egg chamber is shown. Genomic replication has been
shut off but amplification is not observed. The same replication defect was observed
for dDPa2 /Df .
(D') A magnified DAPI image of D showing that the follicle cell nuclei are in fact
present and polyploid.
wild-type wild-type dDPa2 dDPal
Table 1. Replication phenotypes of dE2F and dDP mutants in follicle cells
Chorion Amplification
Genotypes Genomic Absent Reduced Normal Increased Total # of 10B-1 1
Replication(c) Egg Chambers
(Fig. 3C) (Fig. 3D) (Fig. 4A) (Fig. 3B) (Fig. 4C)
dDPF1/+ 0% 16% 8% 76% 0% 38
dDP'/Df 1 8 %(d) 82% 0% 0% 0% 51
dE2F" / dE2F91 or dE2F717 2(a) 5%(e) 43% 30% 21% 0% 61
dE2Fi2 /dE2F 9 ' or Db) 0% 10% 11% 19% 60% 42
" The data are combined for genotypes dE2F"/dE2F 9 and dE2F/dE2F7172
b The data are combined for genotypes dE2F2/dE2F9 and dE2F' 2/Df.
' Genomic follicle cell replication is inappropriate at stages 10B - 11.
d Genomic replication occurred in synchrony in all the follicle cells.
e Genomic replication persisted in a few follicle cells.
BrdU labeling of the dDPa l / Df and dDPa 2 /Df, hsDP/ + mutants along with a
DAPI counterstain revealed that the follicle cell nuclei were present but failed to
initiate amplification (Fig. 3D,D'). In addition, genomic replication continued in some
of these egg chambers (Fig. 3C,C' and Table 1). It is striking that this round of
genomic replication is synchronous, a property of normal amplification (compare Fig.
3C' to 3A' and 3B'). Thus it cannot be the consequence of follicle cell genomic
replication being delayed relative to egg chamber development. The difference
between the phenotypes shown in Fig. 3C and Fig. 3D is likely to result from variation
in the levels of active dDP among egg chambers. Taken together, the phenotypes
suggest that dDP plays a dual role in the regulation of replication in follicle cells. It is
required to shut off genomic follicle cell replication at the same time that it is needed
to activate chorion gene amplification. The results of the BrdU analysis directly
correlate with the severe eggshell defects observed for the dDP mutants.
BrdU labeling of dE2Fi l /Df mutant egg chambers showed that dE2F also is
required for amplification; subnuclear BrdU incorporation was either absent or
greatly reduced in these mutant egg chambers (compare Fig. 4A to 4B). The dE2Fi2
mutation, however, had the opposite effect on amplification. BrdU labeling of dE2Fi2
mutant ovaries revealed significantly larger subnuclear dots (stage 10B and in the
later stages) than those observed in wild type (compare Fig. 4C to 4B). In addition to
the over-amplifying follicle cells, some egg chambers had small patches that
completely failed to incorporate BrdU (data not shown). Thus it appears that in the
presence of truncated E2F, the majority of follicle cells initiate amplification, but
cannot limit the rounds of reinitiation of DNA synthesis within each chorion gene
cluster. The dE2Fi2 mutant phenotype also shows that C-terminal transcriptional
activation and RB-binding domains of dE2F are not required for either repression of
genomic replication or the onset of amplification.
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Figure 4. dE2F is necessary for normal amplification.
DNA replication in stage 10B egg chambers was assayed by incorporation of BrdU
(red staining). Panels A-C are at the same magnification. In dE2Fi l /Df mutant egg
chambers (A) amplifying chorion loci are reduced in size and intensity as compared to
wild-type (B). In the wild-type egg chamber most follicle cell nuclei have 4 spots of
different intensities (circle). It is sometimes difficult to see them in the same focal
plane. In dE2Fi 2 /Df mutant egg chambers (C) the size and intensity of the
amplifying chorion loci is greatly increased. The mutant phenotype makes it easier to
see the four subnuclear dots within each follicle cell nucleus (circle).
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Expression of dE2F correlates with the requirement for E2F/DP activity
Because E2F/DP is required for oogenesis, we examined the expression of dE2F
and dDP in wild-type ovaries. The dDP transcript was constitutively high at all
stages of oogenesis (data not shown). To examine dE2F expression, we used a dE2F
enhancer trap line, dE2Frm 72 9 /+ (Brook et al., 1996; Duronio et al., 1995). 3-
galactosidase staining of ovaries from dE2F'rm 72 9 /+ females revealed a striking
developmental pattern. dE2F transcript was observed at high levels in follicle and
nurse cell nuclei starting at stage 10B (Fig. 5A). The induction of dE2F correlates
with the completion of genomic polyploidization and the transition to amplification in
follicle cells. To analyze the expression of dE2F protein in wild-type and mutant
ovaries, we used antibodies against dE2F (Asano et al., 1996). In wild-type ovaries a
dramatic increase in the levels of dE2F protein in follicle and nurse cell nuclei was
observed at stage 10B, reflecting the induction of dE2F transcript (data not shown).
dE2F protein was also detected in ovaries from the three female-sterile mutants, so
neither the mutations in dE2F itself or in dDP affect dE2F protein stability (data not
shown). We conclude that the temporal and spatial expression of dE2F RNA and of
the dE2F protein match the developmental times at which defects occur in the dE2F
and dDP mutants.
To confirm that dE2F expression correlates with E2F/DP transcription factor
activity we examined the expression of E2F target genes in stage 10B egg chambers.
In wild-type ovaries, PCNA and RNR2 transcripts were observed at low levels during
the early stages of oogenesis. However, both transcripts were induced at stage 10B
(Fig. 5B). In contrast, the level of PCNA and RNR2 transcripts at stage 10B was
dramatically reduced in the dDPal, dE2Fi l , and dE2Fi 2 female-sterile mutants (Fig.
5C and data not shown). In wild-type ovaries cyclin E expression is also induced at
stage 10B, but the level of cyclin E transcripts was normal or slightly diminished in
the mutant ovaries (data not shown). We tested for an effect of E2F on cyclin E by
128
Figure 5. dE2F expression correlates with E2F/DP activity.
Panel A is at a higher magnification than panels B and C.
(A) /f-galactosidase staining of egg chambers from dE2Frm72 9 /+, a dE2F enhancer
trap line (Brook et al., 1996; Duronio and O'Farrell, 1995). A stage 8-9 egg chamber is
embedded between two stage 10B egg chambers. dE2F transcript (blue staining) is
induced at stage 10B. This induction correlates with the transition to amplification in
the follicle cells. The small blue cells are the follicle cells (arrowheads) and the larger
cells are nurse cells (arrow).
(B) PCNA expression in a continuum of developing control dDPa l / + egg chambers.
PCNA transcripts were detected by whole-mount in situ hybridization. PCNA
expression is seen in early egg chambers, but it is highly induced at stage 10B (arrow).
(C) In mutant dDPa l /Df egg chambers PCNA expression is greatly diminished at
stage 10B (arrow). The same effect on PCNA transcription was observed in both of
the female-sterile dE2F mutants.
(D-F) Cyclin E protein levels in wild-type and mutant ovaries following staining with a
monoclonal antibody (Richardson et al., 1995).
(D) A nurse cell nucleus (arrow) and the oocyte (arrowhead) are shown in a control
dDPa l /+ stage 10B egg chamber.
(E-F) The levels of cyclin E protein appear normal in mutant dE2Fi 2 /Df and
dDPa l / Df egg chambers including stage 10B (arrows).
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monitoring the levels of cyclin E protein in wild-type and mutant ovaries with a
monoclonal antibody against cyclin E (Richardson et al., 1995). In dDPa l,
dDPa2 /Df, hsDP/+, dE2Fi l and dE2Fi 2 mutants the levels of cyclin E protein were
normal in nurse cells and follicle cells at all stages, including stage 10B (Fig. compare
5D to 5E,F). Thus, the induction of PCNA and RNR2 transcripts is E2F dependent in
the ovary while cyclin E appears to be dependent on the E2F transcription factor in
some developmental contexts but not others.
dE2F and dDP promote nuclear envelope breakdown and apoptosis in vivo
Because ectopic dE2F expression drives apoptosis (Asano et al., 1996), we
tested whether the female-sterile dDP and dE2F mutations block apoptosis. Nurse
cells become polyploid, transfer their contents to the developing oocyte, and die by
apoptosis (Foley and Cooley, 1998). The transport of nurse cell contents and
subsequent cell death are linked by their requirement for cell death machinery.
Drosophila caspase dcp-1, an essential cell death gene, inhibits the breakdown of the
nurse cell nuclear envelope, and consequently the transport of contents from the
nurse cells to the oocyte (McCall and Steller, 1998). The dramatic increase of dE2F
protein in nurse cells at stage 10B anticipates the transfer of nurse cell cytoplasm to
the developing oocyte. By stage 11, nurse cell nuclei have become permeable and
their contents have diffused into the cytoplasm and are rapidly transferred to the
oocyte via cytoplasmic bridges.
In the dDP and dE2F mutants, the nurse cells persisted well beyond the stage
during which they are normally lost, suggesting a defect in nurse cell apoptosis. In
addition, the oocytes were small, indicating a possible block to the transport of large
amounts of RNA and protein from the nurse cells. Cyclin E and dE2F, proteins that
localize to nurse cell nuclei, failed to diffuse into the cytoplasm even as late as stage
14 (data not shown). We tested whether the nurse cell nuclei become permeable at
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stage 11 or later stages in the dE2F and dDP mutants by antibody staining of
nuclear lamin. In the early egg chambers the nuclear envelope was intact in both the
controls and mutants (Fig. 6A,B). In the dDPa l , dE2Fi l , and dE2Fi2 mutants,
however, the lamin staining persisted beyond the stage when the envelope is broken
down in controls (Fig. 6D-F). The retention of nuclear contents by the mutants,
therefore, resulted from defective nuclear envelope breakdown. We conclude that the
activity of E2F is essential for the breakdown of lamins.
To determine directly whether dDP and dE2F are required for programmed cell
death, we used the TUNEL method for in situ detection of dying nuclei. In wild-type
and heterozygous control ovaries, all 15 nurse cell nuclei stained positively for
TUNEL during stages 12-13 of oogenesis (Fig. 7A). By stage 14, the nurse cells
degenerated, and TUNEL staining was no longer observed (Fig. 7D). In the dDP and
dE2F mutants, however, a cluster of nurse cells remained attached to the stage 14
oocyte and failed to label with TUNEL (Fig. 7B,B',E,E'). Although apoptosis did not
occur at the correct stage in dE2F and dDP mutants, in some egg chambers the
persisting nuclei did stain with TUNEL at a later period (Fig. 7E). This indicated that
apoptosis could eventually occur but was delayed. The results obtained by acridine-
orange staining were consistent with those from the TUNEL analysis (data not
shown). The effect on apoptosis was the same for all the female-sterile mutants:
dDPal, dDPa2 /Df; hsDP/+, dE2Fil, and dE2i 2 . Thus, E2F/DP activity and the C-
terminal region of the dE2F gene promote normal apoptosis.
The dE2F and dDP mutants also allowed us to examine whether E2F/DP
regulates the expression of apoptotic target genes. Reaper is an ideal candidate since
it is transcriptionally regulated and induced prior to the onset of apoptosis (White et
al., 1994). During oogenesis, reaper transcript was first observed during stage 9, but
there was a dramatic induction of reaper at stage 10B (Fig. 7C) (Foley and Cooley,
1998; Nordstrom et al., 1996). Reaper continues to be expressed at high levels
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throughout oogenesis. The induction of reaper is coincident with the induction of
dE2F. Reaper transcript is reduced in the dE2F and dDP mutants (Fig. 7F). Even
though reaper itself appears dispensable for nurse cell apoptosis (Foley and Cooley,
1998), its decrease in the mutants suggests that E2F/DP may regulate apoptotic
genes.
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Figure 6. E2F/DP is required for nuclear envelope breakdown.
Early and late egg chambers were stained with a monoclonal antibody to nuclear
lamin Dmo. The large rings surround the highly polyploid nurse cell nuclei and the
small rings surround the follicle cells. In the early stages, nuclear envelope staining is
identical for the sibling control (A) and the dE2Fi 2 /Df mutant egg chambers (B). At
stage 12, nurse cell nuclear envelope staining becomes diffuse in the controls (C), but
the nuclear envelopes (arrow) persist in the dE2Fi 2 /Df mutant (D). Nuclear lamin
continues to be visible in dDPa l /Df (E) and dE2Fi 2 / Df (F) mutant nurse cells even
at stage 14 (arrows). The same phenotype was observed for the dE2Fi l /dE2F9 1
mutant.
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Figure 7. E2F/DP is necessary for normal apoptosis.
The TUNEL method was used for in situ detection of DNA fragmentation in dying
nuclei. A DAPI counterstain was used to detect all nuclei.
(A) In wild-type ovaries nurse cell nuclei stain positively for TUNEL (purple staining
and arrow) at stage 12. By stage 14 (D) the nurse cells are completely eliminated.
In stage 14 dE2Fi l dE2F71 72 mutant egg chambers (B and E) the nurse cell cluster
remains attached to the oocyte. DNA fragmentation as evidenced by TUNEL
staining does not begin (B) or is delayed (E). Failure to initiate apoptosis at the normal
developmental time is also evidenced by the presence of nurse cell nuclei (arrows) in B'
and E' , the DAPI counterparts to B and E, respectively. The same apoptotic defects
were observed for dDPal / Df and dE2Fi 2 /Df mutants.
(C) Reaper expression (purple staining) in a stage 10B control dE2Fi 2 /+ egg
chamber. Reaper transcripts were detected by whole-mount in situ hybridization.
The transcript is first observed at low levels at stage 9, but it is greatly increased in
the nurse cells and follicle cells at stage 10B and in the later stages.
(F) Reduced reaper expression is shown in a stage 11 mutant dE2Fi2 /Df egg
chamber. The level of expression is comparable to that seen in wild-type stage 9 egg
chambers.
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Discussion
The mutations isolated in dE2F and dDP demonstrate an effect on nurse cell
apoptosis and three examples in which E2F activity influences the activation of DNA
replication origins within S phase (Table 2). First, in all three mutants the genomic
intervals normally underreplicated during the endo cycle were found to be present at
higher levels in the nurse cells. Thus fully functional E2F is required to limit
replication within heterochromatic regions. Second, at a time when all the follicle cells
would normally be undergoing origin firing in only four amplifying regions, in the dDP
mutant the total genome incorporates BrdU. This reveals that E2F is needed to
block general genomic replication origins during stages of egg chamber development
when amplification occurs. Finally, E2F activity influences the extent to which
amplifying regions of the genome replicate. The mutations in dE2F and dDP that
should affect DNA binding block amplification, demonstrating a need for E2F in origin
activation. The truncated form of dE2F, however, permits increased amplification.
This indicates that E2F acts both to activate amplification origins and to restrict the
number of times they fire.
In different developmental contexts we find that E2F activity is necessary
either to inactivate or to activate origins. In mammalian systems E2F has been
observed to act as a repressor when complexed with a pocket protein, but as an
activator when free. Thus one possibility is that the opposite roles observed for E2F
within S phase reflect differing complexes in which E2F resides at differing
developmental points. It is striking that increased levels of amplification occur with a
truncated form of dE2F lacking the RB-binding domain and transcriptional activator
domain. Thus restriction of the extent of amplification origin use may be due to E2F
complexed with RB and acting as a repressor. In contrast, the shut off of follicle cell
genomic replication does not appear to require the RB interaction. E2F's action in
restricting heterochromatin replication, however, could result from its repressor
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Table 2. Summary of dE2F'and dDP" defects
Viability with Shut off of
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Genotypes Mutant Proteins Viability Cyc E dose Apoptosis Replication Replication Amplification
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aThese animals die earlier in development with a two fold reduction of the zygotic cyclin E contribution.
activity in an RB complex, and the mutant effect due to derepression. Another
possibility is that the inappropriate replication arises from decreased ability of the
mutant forms to activate transcription of genes that normally hinder replication.
How does E2F affect replication origins? We envisage two potential
mechanisms. The first possibility is that E2F affects origins in cis, independent of its
activity as a transcription factor. It has been demonstrated that RB, when
complexed to E2F, is capable of recruiting histone deacetylase and thereby
converting chromatin to a compacted state (Brehm et al., 1998; Luo et al., 1998;
Magnaghi-Jaulin et al., 1998). This state is correlated with inaccessibility to
transcription factors, and it is reasonable to propose that it would also hinder binding
of replication factors. Thus in this model E2F in complex with RB would cause
histone deacetylation in the vicinity of replication origins, leading to underreplication
of the nurse cell heterochromatin. A similar mechanism could shut off amplification
origins, and the inability of dE2Fi2 protein to bind RB would prevent shut off in this
mutant. Alternatively, it has been demonstrated in mammalian cells that the
inappropriate binding of E2F to DNA during S phase (due to a failure to interact with
cyclin A) causes S phase arrest (Krek et al., 1995). Therefore, it is possible that an
analogous mechanism could be used during Drosophila oogenesis. For example, E2F
could remain bound in heterochromatin and block replication, and rebind to follicle cell
DNA to cause a shut off of genomic replication.
A more extreme version of the "in cis" model is that E2F directly affects
replication origins. While this model necessitates a previously unrecognized E2F
activity, the ABF transcription factor is known to bind to yeast ARS sequences (Bell
et al., 1993) and transcription factors play a role in viral origin activation (De
Pamphilis, 1993). In addition, cyclin E protein accumulates at amplification sites in
the follicle cell nuclei (Calvi et al., 1998). With polyclonal antibodies against dE2F
(Asano et al., 1996) we were unable to detect dE2F at discrete nuclear foci when
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amplification is occurring (I. Royzman and T. Orr-Weaver, unpublished observations).
This result does not support this model, but it still remains a formal possibility.
An alternative is that E2F mediates its effects on replication indirectly, in
trans, via its role as a transcriptional repressor and/or activator. Several of the genes
regulated by E2F affect DNA replication origins. The transcription of at least one
MCM gene, an ORC subunit, and CDC6 is dependent on E2F (Duronio et al., 1998;
Ohtani et al., 1996; Yan et al., 1998). Chorion gene amplification is diminished in a
female-sterile mutation in orc2 (Calvi et al., 1998; Landis et al., 1997). Thus E2F
activity may be necessary to produce the proteins needed to establish prereplication
complexes on origins.
In the "in trans" model additional explanations are required to account for the
effect of mutations in E2F on origin activity in particular genomic regions. It is
possible that some of the differential effects on replication may be explained by
timing. In a weak allele of cyclin E, heterochromatic replication in the nurse cells is
increased (Lilly and Spradling, 1996). To explain this, Lilly and Spradling proposed
that reduced cyclin E activity leads to dampened oscillations in cyclin E protein
during the nurse cell endo cycles, and this prolongs S phase. During the lengthened S
phase sequences that replicate late in S phase could be replicated in the mutant. In
the dDP and dE2F mutants, S phase does appear to be prolonged (Duronio et al.
1998; Royzman et al. 1997). While an explanation of lengthened S phase can account
for the replication of nurse cell heterochromatin, it is hard to reconcile with the
replication of the total genome in follicle cells in dDPa l , and the failure of
amplification in dDPal and dE2Fi l . However, even in the nurse cells it does not
appear that the dDP and dE2F mutant effects are a consequence of reduced levels of
cyclin E. We failed to detect a reduction in cyclin E transcripts or protein in the
mutant ovaries. Therefore it may be that the cyclin E mutation decreases the
amount of active E2F, altering the replication parameters.
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In addition to the roles within S phase, the mutant phenotypes reveal that
dDP and dE2F promote apoptosis in cells that are destined to die during the normal
course of development. Although ectopic dE2F expression alone is sufficient to induce
apoptosis (Asano et al., 1996), developmental cell death requires the function of the
E2F/DP heterodimer. The observed defects in the dDP and dE2F mutants include
inhibition or delay of DNA fragmentation, failure to breakdown nuclear lamins, and
reduced expression of a pivotal cell death gene. The broad spectrum of apoptotic
defects suggest that E2F/DP plays a regulatory function for the initiation of
developmental cell death. These findings support and extend the previous
observation that cultured thymocytes from E2F-1- - mice are less susceptible to
apoptosis.
The dE2F mutations described in this study have been particularly useful
because they retain some activity. They permitted us to analyze the role of E2F in
replication and apoptosis in a biological context, adult oogenesis, in which the
parameters of S phase could be defined with precision using cell biology. The
surprising contradiction between the molecular nature of the alleles and the weak
phenotypes provides insights into the mechanisms by which E2F influences gene
expression. The dE2Fi 2 allele is particularly striking because it lacks the activation
and RB-binding domains. Yet, in contrast to the dE2F null (dE2F9 1) the dE2Fi2
mutation does not affect viability. The difference in the severity of phenotypes
suggests that a previously unidentified activity in the N-terminus of dE2F is
significant for transcriptional activation in vivo. The dE2Fi l and dDPal mutations
are analogous, yet the two mutants do exhibit some differences in phenotype (Table
2). The dDP mutant fails to extinguish genomic replication in the follicle cells.
Although it is possible that the two subunits of E2F have independent activities, we
favor the interpretation that the absence of an effect on genomic replication in the
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dE2F mutant is due to compensating dE2F protein from a second dE2F gene (D.S.
Huen and N. Dyson, personal communication).
These alleles are relevant also to the activity requirements for E2F in
apoptosis. Recent studies showed that overexpression of transactivation defective
E2F-1 mutants but not E2F-1 DNA-binding mutants can induce apoptosis in cell
culture (Hsieh et al., 1997; Phillips et al., 1997). Further, RB overexpression inhibits
apoptosis induced by wild-type E2F-1 and RB-binding competent E2F-1 mutants
(Hsieh et al., 1997). These observations led to the notion that DNA binding rather
than the transactivation activity of E2F-1 is necessary for its apoptotic function, and
that apoptosis is the result of alleviation of RB-E2F1 repression of apoptotic target
genes. The phenotypes exhibited by the dE2F and dDP mutants do not support this
model. We observed either an apoptotic block or delay in all the mutants tested,
including dE2Fi 2 which lacks the RB-binding domain. Thus, we favor a model in
which the E2F/DP heterodimer is an activator of the apoptotic pathway.
The biological roles uncovered for E2F in this study highlight the importance of
examining mutant loss-of-function phenotypes within a multicellular organism under
different developmental contexts. The dE2F and dDP mutations were recovered due
to a failure to activate E2F-dependent G1-S transcription. However, phenotypic
analysis of the mutants has shown that the role of E2F/DP in S phase is not limited
to the onset of DNA replication. The replication phenotypes observed in dE2F and
dDP mutant adults reveal that E2F/DP controls differential regulation of replication
origins within S phase. This study raises the intriguing possibility that the activity of
transcription factors may regulate the timing and choice of replication origins.
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Materials and methods
Fly strains
dDPal and dDPa2 alleles were described previously (Royzman et al., 1997).
The deficiency uncovering dDP, Df(2R)vg56, was provided by R. Duronio (Duronio et
al., 1998). dE2F7 172 , dE2F9 1, dE2Frm 72 9 alleles (Duronio et al., 1995) and the
transgenic lines P[w+, hsp70-dE2FI, P[w+, hsp70-dDP] were provided by N. Dyson
(Duronio et al., 1996). The deficiency uncovering dE2F, Df(3R)e-BS2 was obtained
from the Bloomington Stock center. The cyclin E0 1 6 72 allele was provided by A.
Spradling (Lilly and Spradling, 1996). Cyclin EPZ5 was provided by J. Roote
(University of Cambridge, UK).
New mutations in dE2F
dE2Fi l and dE2Fi 2 were isolated from third chromosome mutant lines
established in the lab of R. Lehmann (Skirball Institute, New York University,
Medical Center, NY). The EMS mutagenesis and crosses to establish balanced
stocks have been described (Moore et al., 1998). We screened these lines for
mutations that disrupt G1-S transcription by the strategy previously described
(Royzman et al., 1997).
In order to demonstrates that dE2Fi l and dE2Fi2 are mutations in the dE2F
gene, both mutant lines were sequenced. Genomic DNA was isolated from adults
transheterozygous for the mutagenized chromosome and Df(3R)e-BS2. The dE2F
open reading frame was amplified from the mutant genomic DNA, and the PCR
products were sequenced directly by Research Genetics.
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Cytological analysis and microscopy
In situ hybridizations (Tautz and Pfeifle, 1989) were carried out with
digoxigenin-labeled RNA probes exactly as described in Royzman et al. (1997). For
whole-mount in situ hybridization to ovaries, ovaries were prepared as described by
Ephrussi et al. (1991) and treated for 35 min in proteinase K. Subsequent steps were
carried out as for embryos. The reaper cDNA was provided by H. Steller (White et al.,
1994). The f-galactosidase expression pattern in dE2Fm 72 9 ovaries was
determined according to a standard protocol (Montell et al., 1992). TUNEL and
acridine orange staining were used to detect apoptotic cells in ovaries. The ovaries
were processed as described in McCall and Steller (1998). Ovaries assayed for cell
death by TUNEL were counter-stained for 20 min with lug/ml 4',6-diamidino-2-
phenylindole (DAPI; Sigma). In the dE2F and dDP mutants occasional degenerating
early egg chambers (stage 8 and earlier) were observed.
Ovaries were labeled with BrdU as described previously (Lilly and Spradling,
1996). BrdU labeling was visualized using a goat anti-mouse antibody conjugated to
horseradish peroxidase (Bio-Rad) at a dilution of 1:200. Nuclei were counter-stained
with DAPI as above. For antibody stainings, ovaries were fixed in 8% EM grade
formaldehyde (Ted Pella) for 5 min, and extracted for 2 hours in 1% Triton X-100 in
PBS, and then blocked for 1 hour in 1XPBS, 1% BSA, .3% Triton X-100, and 2%
normal goat serum. For detection of cyclin E, a mouse monoclonal antibody 8B10
was provided by H. Richardson and used at a dilution of 1:5 (Lilly and Spradling, 1996;
Richardson et al., 1995). The HRP goat anti-mouse secondary antibody (Bio-Rad)
was used at 1:200. For E2F detection, a rabbit polyclonal antibody was provided by
R. Wharton (Asano et al., 1996) and used at a dilution of 1:100. We showed that this
antibody specifically recognizes dE2F in the ovary, because dE2F9 1 /Df females
rescued to the adult stage by hsE2F did not show protein in the ovary. An HRP-
conjugated goat anti-rabbit secondary antibody (Jackson Immuno Research
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Laboratories) was used at a dilution of 1:100. Nuclear lamin Dm0 staining was
carried out using Abl01l, an antibody provided by K. McCall and H. Steller (Smith et
al., 1987). AblOl was diluted 1:1.5 and detected with a Cy3-conjugated donkey anti-
mouse secondary antibody (Jackson Immuno Research Laboratories) at a dilution of
1:150. The staining pattern with this antibody has been described (McCall and
Steller, 1998) and is similar to that seen with a polyclonal antibody to nuclear lamin
Dm0 (Smith and Fisher, 1989).
A Zeiss Axiophot microscope equipped with Nomarski optics and fluorescence
was used to examine and photograph the embryos and ovaries. Plan-Neofluar 10x,
20x and 40x objectives were used.
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Afterword
153
The roles for dE2F and dDP uncovered in this study provide significant inroads
into understanding the biology of E2F. They also raise mechanistic questions, some
of which can be addressed biochemically. In addition, the dDP and dE2F mutations
can be used as tools to identify interacting genes and further explore the regulation of
G1-S progression and differential replication. Moreover, there are a number of
phenotypes associated with the dDP adult viable allele that have not yet been
explored: more female flies than males flies are recovered, the males are sterile,
female meiosis is defective. The differential effect on female and male viability is very
interesting because it suggests that dDP may have a role in sex determination in
addition to its role in S phase. Genetic approaches can be taken to evaluate this
possibility. In addition to the mutations in dDP and dE2F, the in situ hybridization
screen has also led to the identification of a number of novel genes. These new genes
open yet other experimental directions.
Null mutations in dE2F and dDP cause lethality late in development with
some tissues being underdeveloped or absent. Although lethality is at the
larval/pupal boundary, a pronounced effect on E2F-dependent G1-S transcription was
observed in eight hour embryos. It is clear that the bursts of cyclin E, PCNA and
RNR2 transcription that normally precede S phase are not essential for the G1-S
transition. We postulate that in the mutants the cell cycle could be driven by basal
levels of transcripts, maternal pools of replication machinery, and post-
transcriptional regulation. Late in development the transcriptional activity appears
to be needed, since the mutants die with tissues that are not fully developed. The
dE2Fi2 mutant, therefore, came as a surprise. This mutant completely lacks the
transcriptional activation domain of dE2F, but viability is not affected. Thus, the
bursts of E2F-dependent G1-S transcription appear not to be needed even in late
development.
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The difference in the severity of phenotype between the dE2F2 mutation and
the null is striking but difficult to reconcile with all that we know about the E2F
protein from studies using mammalian cells. dE2F i2 retains significant physiological
activity that cannot be explained simply by lack of RB-mediated repression, since a
null also lacks RB-mediated repression. The possible explanations seem to be the
following: (1) a previously unidentified activity in the N-terminus of dE2F is
significant for transcriptional activation in vivo (although the bursts of S phase
transcription are not observed by in situ hybridization in the dE2F" embryo or adult);
(2) dE2F transcriptional activation is not essential for viability but instead DNA
bound dE2F is used as a docking site by other molecules to regulate chromatin
structure or in some other way to affect transcription. These possibilities are difficult
to address experimentally. It is feasible to create different mutant form of dE2F and
to put them back into the fly. It would be very striking if a region of dE2F that can
only dimerize with dDP and bind DNA could rescue the dE2F null. The other way to
try to understand what dE2F is actually doing is to take a genetic approach and to
isolate functions that depress the activity of dE2F 2. For example, one could look for
enhancers that would change the lethal phase of the dE2Fi2 mutant from the adult to
a pupal stage. This is a long haul but is likely to ultimately provide significant
insights into the activity of dE2F.
The increased levels of amplification in the dE2Fi 2 mutant as compared to wild
type suggest that E2F/DP may affect origins independently of its role as a
transcriptional activator of S phase genes. Further experiments are needed to
evaluate this possibility. The cis-acting elements involved in chorion gene
amplification have been identified. Biochemical approaches can be taken to
determine whether E2F/DP is bound in the vicinity of these elements. A specific
interaction of E2F/DP with these cis-acting elements would provide support for a
model where E2F/DP affects the activity of DNA replication origins "in cis" rather
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than through the transcriptional activation or repression of other proteins. In the
best scenario, the biochemistry would be confirmed by cytology. I did not see dE2F
localize to subnuclear foci with a polyclonal dE2F antibody (see Chapter 4). However,
possibly a monoclonal antibody against dE2F may reveal subnuclear dE2F
localization, and the identity of the subnuclear foci can be verified with anti-dE2F and
anti-BrdU double labeling.
A number of genetic screens can be initiated to identify genes that regulate the
G1-S transition and differential replication. The dE2F and dDP adult viable mutants
could be used as a starting point to obtain genes that are involved in the same
biological process. It should be possible to alter the mutant phenotype of interest due
to a twofold reduction in the zygotic contribution of an interacting gene. For example,
one could look for dominant suppressers or enhancers that alter the lethal phase of
the dDP1 mutation from reduced viability to full viability or pupal lethality. The
interacting genes may be regulators of the G1-S transition or essential replication
genes. A possible added bonus is that suppressers or enhancers of the differential
effect on male and female viability in the dDP"1 mutant may also be recovered.
These may turn out to be known regulators of sex determination and would support a
role for dDP in the sex determination pathway.
Two possible screens could be carried out to identify genes involved in
differential replication control: (1) a screen for suppressers of the over-replication
phenotype in mutant dDP or dE2F nurse cell nuclei; (2) a screen for suppressers of
the chorion amplification defect in the dDP1 or dE2Fii mutants. The first screen is
somewhat labor-intensive because it involves dissecting ovaries and DAPI staining.
The second screen is more attractive because it is simpler; it is very easy to discern a
change from thin eggshells in the non-amplifying mutants to the normal white
eggshells. The identification of gene products that interact with E2F/DP may help to
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determine how E2F/DP acts to positively and negatively regulate origin activity
during S phase.
It is possible to characterize and clone the other mutations identified in the in
situ hybridization screen and discussed at the end of Chapter 2. These mutations
have highly specific effects on S phase reporter genes and may provide considerable
insight into the control of DNA replication. 1(2)51Ec is especially interesting because
it appears to be required both for S phase entry as well as the completion of S phase.
Because the screen has been successful on the second chromosome and the
technique for carrying out in situ hybridizations on multiple lines has been perfected
to allow relatively rapid screening, it would be very interesting to extend the screen to
the X chromosome. A comprehensive screen on the third chromosome is also worth
doing, since only a 1000 mutagenized lines have been examined. This approach may
lead to the identification of a regulator that is specific to the endo cycle, and certainly
additional S phase regulators that are shared by mitotic and endo cycle tissues would
be isolated.
The phenotypes associated with the adult viable dDP and dE2F mutations
really support the approaches discussed in the appendix for identifying hypomorphic
mutations in genes important for endo cycles. The dDP and dE2F mutants meet all
the phenotypic criteria that I used to select putative endo cycle regulators: reduced
body size, bristle defects, and female sterility. diminutive, Drosophila myc, also meets
the same criteria. In contrast to my expectations when I first initiated the EMS
screen for small adults and ordered existing small fly mutants (see Appendix),
mutations in genes that promote endoreplication (dDP, dE2F and dmyc) do not cause
a dramatic reduction in the level of nurse cell polyploidy. I think with this observation
in mind, it would be worth examining existing mutations that cause small adults.
Additionally, the relationship of dE2F and dDP with dmyc could be explored.
The phenotypes of the hypomorphic dDP, dE2F, and dmyc alleles are very similar;
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the effects on bristles are identical. Moreover, dmyc and dmax transcripts are
expressed in the pattern of S phase reporter genes and DNA synthesis in late
embryos (Gallant, et al. 1996); the expression in the CNS is relatively low but it is
quite robust in the endodomains. It is likely that both transcripts are E2F/DP
dependent. This can be readily determined by examining dmyc and dmax transcripts
in the background of an dE2F null or dDP null mutant. It would be also interesting to
look for a genetic interaction between dE2F (or dDP) and dmyc. The ovaries form
dmyc mutant females can also be examined by DAPI staining for effects on late
replication of heterochromatin. I did not specifically look for this phenotype in my
initial characterization of this mutant.
The identification of gene products involved in the G1-S transition and
differential replication will enable us to understand the molecular mechanisms that
control these processes and the role of E2F/DP.
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Appendix
Using small-fly mutants to identify regulators of the endo cycle
Irena Royzman and Terry L. Orr-Weaver
Whitehead Institute and Department of Biology, MIT
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The endo cycle begins during Drosophila embryogenesis and consists of
alternating DNA synthesis and gap phases (Smith and Orr-Weaver 1991). This
modified cell cycle leads to the production of polyploid and polytene cells. Drosophila
larvae use polytenization rather than proliferation as the primary mechanism of
larval growth. The switch from a mitotic cycle to the endo cycle is a recurrent theme
in Drosophila development. In addition to the switch in embryogenesis, bristle
precursor cells within the pupal epidermis, and the nurse and follicle cells of the adult
ovary become polyploid.
My studies of the regulation of the endo cycle began with a screen for
mutations that cause small adults. The hypothesis underlying this approach was
that since larval growth is achieved by increasing the ploidy of larval cells, a partial
block to the endo cycle should result in small larvae and small pupae which give rise
to small adults. In addition, compromised ability to undergo endo cell cycles is
expected to cause female sterility and bristle defects. Females homozygous for a
hypomorphic mutation should be sterile due to deficient polyploidization of the nurse
cells. Bristle shafts and sockets were expected to be shorter and smaller respectively
since the bristle precursor cells (trichogen and tormogen cells) undergo endo cycles
(Lees and Waddington 1942). More severe phenotypes were expected when the
mutation is put over a deficiency.
We suspected that both cell cycle and nutritional mutants could give rise to a
small adult phenotype. Mosaic analysis would be used to differentiate between these
two classes of mutants. Endo cycle regulator mutations, unlike nutritional
mutations, were expected to have an immediate effect in a homozygous clone. The
effect on nurse cells and bristles could then be examined soon after the induction of a
homozygous clone.
I carried out an F1 screen for EMS induced mutations on the X chromosome
that cause small adult males (Fig. 1). Isogenized yw males were fed 35 mM EMS and
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mated to virgin females from a virginator stock ( C(1)M4, y / shits lyY). The
virginator stock eliminated the need to collect virgins in the parental cross because
males die at 29 0C due to the shits X chromosome. In addition, a recessive mutation
on the X chromosome could be seen in the F1 generation in the male progeny. I made
sure to avoid over-crowding of the mutant progeny to avoid false positives due to
environmental conditions. Also, because small adults are known to eclose later than
wild type, I collected the F1 progeny both early and late in order not to miss the males
that eclose a few days late. 5385 females and 2433 males were recovered from the
parental cross. The mutagenesis, therefore, caused approximately 55% sex-linked
lethals. Of the 2433 males, 13 putatives were retested. 6 of the small males were
sterile, and the other 7 did not breed true.
I decided not to pursue the F1 screen further due to two problems with this
approach. It was not clear at the time the degree to which a weak mutation in an
endo cycle regulator would affect the size of the flies. In addition, EMS causes a high
frequency of mosaicism (Ashburner 1989). This makes it difficult to recover
mutations from an F1 screen.
In addition to the F1 screen for small males, I examined a number of already
existing mutants that have defects in tissues which undergo endo cycles. The most
promising candidates were diminutive, tiny, and minus, because the mutant adults
were small, female sterile, male fertile, and had reduced bristles. diminutive is a
hypomorphic mutation with a striking bristle phenotype that becomes more severe
over deficiency (Fig. 2). In addition, the tergites are etched; this is consistent with a
role for diminutive in the mitotic cell cycle as well (Fig. 2). Therefore, diminutive is
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Fig. 1 F1 screen for mutations on the X chromosome
that cause small adults.
Isogenized yw males were mated to C(1)M4, y / shits / y + Y
virgin females. 2433 mutant males were examined from
the parental cross. 13 putative small males were
mated singly to C(1)M4, y /shits ly+Y virgins and retested.
6 of the males were sterile and the other 7
not breed true.
Figure 2. Bristle defects in the dm mutant.
(A) dm/dm scutellar bristles are more thin and
reduced as compared to wild-type bristles.
(B) The mutant phenotype is even stronger over the
deficiency. dm/Df scutellar bristles are very thin and
short, one is missing.
(C) dm/+ bristles and tergites.
(D) dm /Df bristles are reduced in number and
in size and the tergites are etched.
not a specific regulator of the endo cycle. The nurse cell phenotype as revealed by the
DNA dye DAPI was not pronounced, and I did not pursue diminutive further. tiny was
also not pursued because cytological examination of the mutant ovaries did not reveal
a decrease in the levels of polyploidy in nurse cells and follicle cells. Interestingly, it
has been shown recently that diminutive encodes a Drosophila homologue to the
mammalian oncogene myc (Gallant, et al. 1996; Schreiber-Agus, et al. 1997).
DAPI staining of minus mutant ovaries revealed a distinctive phenotype.
Normally, nurse cell endoreplication results in polytene chromosomes during the early
stages of oogenesis (prior to stage 4). However, at stage 4 the polytene nurse cell
chromosomes dissociate, so the nurse cell nuclei become polyploid (Spradling 1993).
The nurse cells continue to undergo endo cycles but the nuclei remain polyploid for the
remainder of oogenesis. The transition from polyteny to polyploidy is not understood.
It is thought that separation of polytene chromosomes may involve chromatin
condensation and therefore may require some mitotic activities. In the minus
mutant the nurse cells are able to undergo endo cycles but the normal progression of
chromatin reorganization is defective; condensed chromosomes can be seen even at
late stages of oogenesis (Fig. 3). In addition, minus mutant mothers can occasionally
lay eggs. These eggs do not develop, and DAPI staining of the eggs revealed that they
are arrested during the early embryonic divisions with 8-32 nuclei. It is possible that
minus provides an essential mitotic function in embryos and at the transition from
polyteny to polyploidy in the ovary.
I mapped minus extensively using deficiencies in region 59. The position of
minus relative to these deficiencies and other genes in the 59 region is included in the
thesis of Dan Moore (Moore 1997). These same deficiencies were used by Sharon
Bickel to define the ord gene molecularly (Bickel, et al. 1996), and it seemed likely
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Figure 3. The oogenesis phenotype of minus. A basic fuchsin stain was
used to visualize DNA in egg chambers from wild-type (A,C) and minus
mutant females (B,D).
(A) In wild-type egg chambers the nurse cell nuclei are polytene prior to
stage 4; the chromosomes become bulbous at stage 4 and by stage 5 (S5)
the nurse cell nuclei appear polyploid rather than polytene.
(B) In contrast, in minus mutant egg chambers the transition from polytene
to polyploid nurse cell nuclei is defective. The chromosomes appear polytene
at stage five.
(C) A late wild-type egg chamber is shown. The 15 nurse cell nuclei are
polyploid.
(D) In late minus mutant egg chambers the nurse cell nuclei have increased
in size but the chromatin remains condensed (arrow).
that minus is contained in the molecular walk for ord. I felt that a molecular analysis
of minus would not yield insight into the regulation of S phase or the switch from a
mitotic cycle to an endo cycle. Consequently, I did not pursue the phenotypic or
molecular characterization of minus further. Instead, I embarked on a genetic screen
to identify regulators of S phase in mitotic and polytene cells in the embryo.
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